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INTRODUCTION 
 
 Extubation is often associated with varying degrees of problems. The appropriate 
 
 time to remove an endotracheal tube is part of the art of anaesthesia that develops with 
 
 experience. Both intubation and extubation are associated with rise in heart rate and  
 
blood pressure, yet often there has been less emphasis on avoiding hemodynamic changes  
 
at extubation. These cardiovascular changes occur due to release of catecholamines at  
 
extubation, in addition to pain from the surgical site  and irritation of the tracheal mucosa  
 
by the endotracheal tube. 
  
 Coughing is another very common problem encountered at extubation. The 
mechanism of cough is presumed to be irritant or stretch stimuli in the trachea caused by 
the endotracheal tube and its cuff. Coughing and the hemodynamic response at 
extubation  can result in potentially dangerous patient movements, hypertension, 
tachycardia, or other arrhythmias, myocardial ischemia, surgical bleeding, bronchospasm 
and increase in intracranial pressure and intraocular pressure. 
 In patients coming for  neurosurgical procedures, it is important to avoid factors 
such as coughing and hypertension at emergence, which are likely to cause raised 
intracranial pressure and intracranial bleeding. Any increase in intracranial pressure can 
adversely affect the postoperative outcome. 
 Awakening and extubation after anaesthesia are associated with hemodynamic 
arousal lasting 10 to 25 minutes, partially mediated by elevations in catecholamine levels 
and partially by nociceptive stimuli. Thus both anti-sympathetic (betablockers) and 
antinociceptive (narcotics, lignocaine) treatment strategies are appropriate to decrease 
extubation response.  
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Lignocaine has long been used to modulate the unwanted airway and circulatory 
reflexes seen in response to emergence and extubation. The administration of lignocaine 
has been through several routes such as intravenous (IV) injection, endotracheal cuff, or 
intratracheal (IT) instillation. 
 
 In this study we have compared the efficacy of lignocaine administered via the 
 
 endotracheal tube to lignocaine administered intravenously , and to placebo, in 
suppressing 
 
 the extubation response. As a smooth extubation at the end of surgery is vital for a good 
  
outcome in neurosurgery, we have done this study in patients undergoing craniotomies.  
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AIMS AND OBJECTIVES 
 
 
 
1. To determine whether intratracheal instillation of lignocaine is effective in 
 attenuating airway & circulatory response to extubation. 
 
2. To determine if the effect of intratracheal route is by absorption from the 
mucosa or if it has any local mucosal anaesthetizing  effect.  
 
3. To determine if awakening from anaesthesia is delayed with the use of  
lignocaine and to compare the time taken for extubation between the groups 
 where lignocaine is used.  
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LITERATURE REVIEW 
 
Tracheal extubation at the end of general anaesthesia is often associated with 
varying degrees of problems. Problems during extubation can vary from mild cough to 
severe hemodynamic changes which can be catastrophic. Anesthesiologists are 
increasingly focussing their attention on complications associated with emergence from 
anesthesia and endotracheal extubation. (1) In fact, a recent study suggested a greater 
incidence of respiratory complications associated with endotracheal extubation than with 
endotracheal intubation.(2) Emergence from anaesthesia has respiratory, cardiovascular, 
metabolic, endocrine, and neurologic consequences. These include coughing, increase in 
intracranial and intraocular pressures, tachycardia, hypertension, myocardial ischemia, 
increased surgical bleeding, laryngospasm and bronchospasm. (3) 
Common problems encountered at extubation are as follows. 
1. Coughing at emergence. 
  The incidence of coughing at extubation may be as high as 96% as estimated by 
Gonzalez et al. (4) Coughing is a well recognised phenomenon associated with 
extubation in almost every patient undergoing general anaesthesia. Kim and Bishop (5) 
showed a 76.5% incidence of coughing during emergence, regardless of smoking history. 
Smooth emergence from general anaesthesia with minimal coughing is often considered a 
hallmark of an experienced anesthesiologist, and clinicians generally attempt to prevent 
patients from coughing at the end of a procedure. (5)      
Asai et al did a prospective study in 1005 patients who underwent general 
anaesthesia, to assess respiratory complications during intubation and extubation. They 
proved that the most common respiratory complication during extubation was coughing, 
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followed by oxygen desaturation and airway obstruction (2).Coughing increases systolic 
and diastolic blood pressure significantly, as well as intraocular and intracranial 
pressures. Intraocular pressure can increase upto 30 to 40 mmHg during coughing, 
causing complications such as vitreous loss in cataract extraction procedures.(6) 
                 A number of techniques have been used to diminish cough during emergence. 
Administration of intravenous (IV) opioids or intravenous lignocaine before emergence is 
useful due to the antitussive properties of these drugs, but leads to delayed emergence 
and can be unpredictable. (7,8,9) Deep extubation can be done but the incidence of other 
respiratory complications such as airway obstruction, laryngospasm and aspiration after 
tracheal extubation is greater when the trachea is extubated while the patient is still 
deeply anaesthetized.(2) 
        The respiratory tracts , contain many receptors located in the larynx, trachea, 
carina and bronchi.  As patients emerge from general anesthesia, the stimulating effect of 
positive pressure ventilation on the mechanosensitive receptors of the trachea and larger 
bronchi may provoke coughing.(10) There are three main types of sensory receptors in 
the respiratory tract : rapidly acting chemoreceptors with small diameter myelinated 
fibres, slowly adapting stretch receptors with large diameter myelinated fibres, and 
polymodal endings of non myelinated nerve fibres.   The mechanism of cough is 
presumed to be irritant or stretch stimuli in the trachea caused by the endotracheal tube 
(ETT) and the cuff .(11) Rapidly acting receptors are  primarily superficial. They are 
thought to be the irritant receptors involved in the cough reflex .(12) The rapidly acting 
chemoreceptors and mechanoreceptors located around the circumference of the trachea 
and the main bronchi are concentrated in the more proximal airways and thus may play 
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an important role in the cardiovascular responses to mechanical stimulation of those parts 
of the airways. As most of these airway receptors are located just below the epithelium, it 
should be possible to block them by topical application or infiltration of local 
anaesthetics in the area stimulated.  
Cough reflex can include bucking, expiration reflex or a true cough. Coughing 
and bucking are not only aesthetically unpleasant but also can be harmful.(13) 
            Bucking is a forceful protracted cough which physiologically mimics a valsalva 
manoeuvre. Unlike a Valsalva maneuver, bucking occurs at variable lung volumes, which 
are often less than vital capacity.(14) Bucking also results in a decrease in functional 
residual capacity. Bucking, especially in pediatric patients, can rapidly cause hypoxemia, 
not only due to the decrease in minute ventilation but also subsequent to the associated 
loss in lung volume and resultant atelectasis. The persistence of relative hypoxemia after 
bucking itself resolves illustrates the greater time and difficulty needed to reexpand the 
lung compared to the ease with which it collapses. (8) 
                        Coughing is a physiological response to protect the airway from 
aspiration. But coughing at emergence can cause potentially dangerous hemodynamic 
changes like tachycardia, hypertension, and rise in intra ocular and intra cranial 
pressures.(7,15,16).It can cause abrupt increase in intracavitary pressures,leading to 
dehiscence of abdominal wounds. (14) 
  Coughing can increase intrathoracic pressures and lead to reduced venous return 
to the right atrium.(17) The sudden increases in intrathoracic pressure are transmitted to 
both arteries and veins and the transient increase in both cerebral arterial and venous 
pressure have the potential consequences of edema formation ,bleeding and emergence 
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from anaesthesia. Coughing decreases coronary perfusion pressure and coronary blood 
flow as a consequence. (16) Coughing and bucking probably indicate the ability to 
protect the airway, but the timing of awake extubation remains a matter of clinical 
judgement.(18)The avoidance of bucking during extubation is one of the hallmarks of a 
smooth extubation and is an important clinical skill and art.(8,15) 
2. Hemodynamic response to extubation. 
  Emergence from anaesthesia is associated with hemodynamic arousal lasting 10 
to 25 minutes, partially mediated by elevations in catecholamine levels and partially by 
nociceptive stimuli. Most patients are extubated in a light plane of anaesthesia and they 
manifest an increase in heart rate and blood pressure during extubation which persist into 
the recovery period.  Dyson and colleages showed that in ASA grade 1& 2 patients when 
extubation was done on eye opening to command, there was a 20% rise in heart and 
blood pressure, in 70% patients. (19) Although the exact mechanism of these 
cardiovascular responses is unknown,it is believed to be associated with the release of 
catecholamines causing increases in heart rate, myocardial contractility and systemic 
vascular resistance.(20). Post extubation hemodynamic responses are brief and well 
tolerated by most patients.but they can cause significant clinical problems in susceptible 
patients, as in hypertensives, neurosurgical and ischemic heart disease patients.   
           These metabolic responses (increased oxygen consumption,catecholamine 
secretion) and cardiovascular responses( tachycardia and hypertension )may adversely 
affect the balance between the myocardial oxygen supply  and demand, resulting in 
myocardial ischemia especially in  patients with ischemic heart disease.(21) This can 
happen even after coronary artery bypass graft surgery.(22) Coriat et al. (17) 
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demonstrated that patients with coronary artery disease experience significant decreases 
in ejection fractions (from 55% ± 7% to 45% ± 7%) after extubation. The changes in 
ejection fraction occurred in the absence of electrocardiographic signs of myocardial 
ischemia. Wellwood et al.(22) reported that patients with a cardiac index of less than 3.0 
L / min/ m-* did demonstrate an ischemic response to the stress of postoperative tracheal 
extubation after myocardial revascularization. These patients experienced decreases in 
myocardial lactate extraction, left ventricular compliance, and cardiac performance.  
                     Hypertensive patients may exhibit an exaggerated hypertensive response to 
awakening and tracheal extubation compared with that seen in normotensive patients. 
Such hypertensive crises may result in cardiac decompensation, pulmonary oedema or 
cerebral hemorrhage.(20) Tracheal extubation after caesarean section in parturients with 
gestational hypertension can cause significant increases of 45 and 20 mm Hg in mean 
arterial and pulmonary artery pressures, respectively. It was concluded that tracheal 
extubation and related hemodynamic changes increased the risk of cerebral hemorrhage 
and pulmonary edema in those parturients. 
Hence most practitioners of  anaesthesia believe that a premium must be placed 
on “smooth” emergence, that is, one free of coughing ,straining and hypertension.(18) 
3. Trauma to any structure in  the upper or lower airway. 
Trauma to the larynx and vocal cords is likely after a difficult extubation and it is 
recommended that laryngoscopy should be always performed immediately after 
extubation if attempts to remove the endotracheal tube have been forceful and repeated. 
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4. Airway obstruction. 
  This can occur at extubation due to laryngospasm, laryngeal edema, vocal cord 
paralysis or due to tracheal collapse. Laryngospasm is the commonest cause of upper 
airway obstruction after extubation .This is precipitated by local irritation of vocal cords 
by secretions or blood, when the plane of anaesthesia is insufficient to prevent 
larngospasm reflex, but too deep to allow a co-ordinated cough. Laryngeal edema can be 
supraglottic,retroarytenoid or subglottic edema.This is mostly symptomatic in 
children.(18)Vocal cord paralysis may occur due to damage to the vagus nerve or its 
branches after surgeries in the neck, prolonged intubation or even compression by the 
tracheal cuff.Tracheal collapse may result from prolonged tracheal compression by an 
enlarged goitre or a thoracic tumour. All these can contribute to hypoxemia and 
haemodynamic changes. 
5. Pulmonary edema. 
Pulmonary edema usually occurs within minutes of either development of acute 
upper airway obstruction or after relief of obstruction.The markedly negative 
intrathoracic pressure generated during an episode of acute upper airway obstruction is 
probably the dominant pathophysiological mechanism.(20) 
6. Pulmonary aspiration of gastric contents. 
This occurs in patients whose protective laryngeal reflexes are obtunded by 
residual effects of local or general anaesthetic agents. 
7. Post operative sore throat. 
Sore throat is a frequent complaint in the  postoperative period following tracheal 
intubation, with an incidence of 59-76%. Mechanisms contributing to this include 
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pharyngeal, tracheal and laryngeal sources. Factors that affect its incidence include area 
of cuff-trachea contact, use of lignocaine ointment, size of endotracheal tube and the use 
of succinyl choline. Drying out of mucosal membranes in the trachea following 
anaesthesia by face mask also contributes to postoperative sore throat. (18) 
  8. Difficulty in extubation. 
This is a dangerous complication but is not commonly encountered. Three basic 
mechanisms contribute to this dangerous complication: failure to deflate the tracheal tube 
cuff, an excessively large cuff impinging on the vocal cords, adhesion of the tube to the 
tracheal wall or because it is transfixed by a suture or wire to an adjacent structure. (20) 
EXTUBATION IN NEUROSURGERY PATIENTS AFTER CRANIOTOMIES. 
In patients undergoing  neurosurgical procedures, it is important to avoid factors 
such as coughing, bucking and hypertension at the time of emergence which are likely to 
cause raised intracranial pressure, intracranial bleeding and worsen cerebral edema. 
Craniotomy is commonly undertaken for primary and metastatic neoplasms of the 
brain and other intracranial space occupying lesions with or without raised intracranial 
pressure (ICP). Post operative outcome of these patients depends on the delicate balance 
between cerebral blood flow and ICP throughout the perioperative period. Patients with 
intracranial space occupying lesions after craniotomies will have an abnormal intracranial 
pressure volume relationship and may develop precipitous increase in intracranial 
pressure if cerebral venous pressure increases on coughing.(3) 
Intracranial compliance is determined by measuring the change in ICP response to 
a change in the intracranial volume. Normally increases in volume are initially 
compensated. A point is eventually reached, however at which further increases produce 
precipitous rises in ICP.(23)Major compensatory mechanisms include  
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1. Initial displacement of CSF from the cranial to the spinal compartment. 
2. Increase in CSF absorption  
3. Decrease in CSF production  
4. Decrease in total cerebral volume (primarily venous) 
             (23)As explained above, an increase of intracranial volume is 
compensated by displacement of C.S.F from the cranium. However, in patients 
with space occupying lesions, this mechanism maybe insufficient and the ICP 
may increase dramatically. This can occur even if the initial ICP is normal but the 
intracranial compliance is decreased. Under such conditions the mechanisms for 
compensation are already exhausted. Therefore sudden increase in ICP in the 
perioperative period must be strictly avoided.  
   
  
 
 
 
 
1, 2 : compensation phase        3, 4: decompensation phase 
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         Abrupt rise in ICP may result in herniation of the brain or impairment of 
cerebral perfusion, causing cerebral ischemia. (24) 
Sustained increase in ICP may lead to the catastrophic herniation of the brain at 
one of the four sites. 
1. Cingulate gyrus under the falx cerebri. 
2. uncinate gyrus through tentorium cerebelli 
3. cerebellar tonsils through foramen magnum. 
4. beneath a defect in the skull-transcalvarial.     (23) 
                  Donegan and Bedford, White et al reported that intracranial pressure 
increased in comatose patients whose tracheas were suctioned. Both authors 
hypothesized that coughing after endotracheal suctioning increased ICP by 
increasing intrathoracic pressure, cerebral venous pressure and cerebral blood 
volume. (24) It raises intracranial pressure through a direct effect and via an 
indirect effect by increasing mean blood pressure.(25)  Hence it is necessary that 
patients undergoing neurosurgical procedures should have a smooth extubation, 
i.e .emergence must be slow and controlled.  
The two most important factors affecting the cerebral blood flow and ICP at 
extubation are the hemodynamic effects and the act of coughing which occur during 
emergence. Controlling these two parameters during extubation is mandatory to blunt any 
untoward increase in ICP or CBF which can adversely affect the postoperative outcome. 
Constantini S et al proved that in the early post op period, after elective 
craniotomies, autoregulation is often impaired, with 20% patients developing raised 
ICP.(26) Gibson et al  showed that 91% of patients undergoing craniotomy had high 
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blood pressure during emergence.(27) In such patients, autoregulation of cerebral blood 
flow is disturbed and a sudden increase in arterial pressure may lead to increase in both 
cerebral blood flow and intracranial pressure. Arterial hypertension is also associated 
with postoperative intracranial hemorrhage.(21) 
 Ideally, patients recovering from neurosurgery should emerge rapidly from 
anaesthesia to provide immediate assessment of the neurological outcome following 
surgery and to provide a baseline for continuing postoperative neurological follow up. 
(28)  Hence,it is of utmost importance that recovery from neuroanesthesia should be 
smooth and progressive, with no major hemodynamic or metabolic disturbances. It 
should also be rapid to allow neurological assessment. These two conditions may not be 
compatible, in all cases.  
          In the past, a postoperative stabilization period was probably indicated because of  
perioperative hypothermia, cardiovascular disturbances due to blood loss or the use of 
controlled hypotension, or cerebral edema due to excessive brain retraction. 
(21)However, progress achieved in surgical and anesthetic techniques  has diminished the 
indications of delayed awakening.(29)  
   Indications for late emergence.                   (28) 
1. Obtunded consciousness or inadequate airway control preoperatively; 
2. intraoperative catastrophe; 
3. significant risk of brain edema, raised ICP, or deranged intracerebral hemo- or 
homeostasis postoperatively. 
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 Early vs. delayed awakening: pros and cons 
Early Awakening Delayed Awakening 
Pros Pros 
Allows earlier neurologic examination and 
reintervention  
Provides baseline neurological status for 
subsequent examinations  
Less postoperative hypertension, catecholamine 
burst  
Performed by anesthesiologist who knows patient 
Surgery/recovery period separated, less costs 
Less risk of hypoxemia and/or hypercarbia  
Better respiratory, hemodynamic control  
Easier to transfer to the ICU  
Stabilization in same state as during surgery  
’Provides better late hemostasis 
Cons Cons 
Increased risk of hypoxemia, hypercarbia  
Respiratory monitoring during transfer to ICU 
Less neurologic monitoring  
Associated with more hypertension, 
catecholamine release  bleeding 
ICU, intensive care unit. 
 
Risk factors for delayed awakening: 
a) long (>6 hours) and extensive surgery (particularly with bleeding),  
b) repeat surgery, 
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c)  surgery involving or close to vital brain areas,  
d)  surgery associated with significant brain ischemia (e.g., long vascular clipping 
times, extensive retractor pressure). 
                                                                                                                                                               
In patients after craniotomies, extubation criteria must be strictly observed because 
central drive and airway protection are likely to be impaired after brain surgery, and both 
hypercapnia and hypoxia can cause additional brain damage. (28) 
Aims of emergence after craniotomy are: 
a. Maintain intra- or extracranial homeostasis (Mean arterial pressure-Cerebral perfusion 
pressure-Cerebral blood flow-Intracranial pressure,  Cerebral metabolic rate of oxygen 
CMRo2, Partial pressure of CO2,    O2, temperature). 
b. Avoid factors leading to intracranial bleeding (e.g., coughing, intratracheal suctioning, 
ventilator fight, rise in blood pressure). 
c. The patient should be calm, cooperative, and responsive to verbal commands soon after 
emergence to allow for neurological status monitoring. 
Therefore it would be useful to assess the level of sedation at the time of extubation. 
Sedation has been assessed using various sedation scores including Modified Ramsay 
sedation score, Observer’s Assessment of Alertness and Sedation Score, etc. 
One of the sedation scores used by Berkenbosch ,Fitchter et al (29) used in  
paediatric intensive care unit which was found to correlate with BiSpectral Index   was as 
follows. 
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1- Awake, alert, 2-occasionally drowsy, 3- frequently drowsy, 4-Somnolent . 
       It has been 30 years since John Bonica, the great anesthesia-based pain 
educator, expressed concern that pain was not well controlled because of the failure 
of physicians to apply available knowledge. That thought may hold more credence in 
the area of neurosurgery than in any other area of postoperative pain treatment. The 
shortcomings in this arena can be attributed to the common belief of clinicians that 
pain is minimal after intracranial procedures. Because of this controversial notion, 
many patients are undertreated in the immediate postoperative period.(30) 
                Other factors, including the need to monitor neurologic and cognitive functions 
closely, contribute to this problem. This monitoring can be affected adversely if the 
patient is sedated or obtunded with more potent opioids. This conflict of treatment goals 
can lead to withholding pain medication and techniques. It has also led to the use of less 
potent opioids for neurosurgical procedures.. The use of new rapidly acting intravenous 
agents has led to rapid wake-up and recovery and unfortunately to the increased 
importance of postoperative pain assessment. With the rapid breakdown of these agents, 
the patient has no opioid level present and may experience significant pain on 
awakening.(30) 
.       It is critical to realize that the treatment of pain in the neurosurgical patient may 
influence outcomes in a variety of ways. Studies have shown that pain in the 
postoperative period can adversely influence ICP. Proper pain control may stabilize 
hemodynamics and blood pressure as well as lower the ICP.  Recovery from 
neurosurgical anesthesia is followed by elevations in body oxygen consumption and 
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serum catecholamine concentrations.(21) Systemic hypertension during emergence from  
neurosurgical procedures  has been linked to intracranial hemorrhage. Raised blood 
pressure can cause cerebral hyperemia and increased ICP. Prevention or control of pain is 
one of the major factors in limiting these adverse systemic effects. 
Over the past decade, developments in intravenous opioids, new regional techniques, and 
local anesthetics have greatly enhanced our abilities to treat this patient group. (30) 
Preemptive analgesia may lead to the improved stability of the patient throughout the 
surgical experience. To minimize pain and decrease the stress response and 
hemodynamic changes, the surgeon and the anesthesiologist must work as a team.(28) 
 Awakening and extubation after anaesthesia are associated with hemodynamic 
arousal lasting 10 to 25 minutes, partially mediated by elevations in catecholamine levels 
and partially by nociceptive stimuli. Thus both anti-sympathetic (betablockers) and 
antinociceptive (narcotics, lignocaine) treatment strategies are appropriate to decrease 
extubation response. (28) A technique that would allow patients emerging from 
anesthesia to tolerate an endotracheal tube, while also affording airway protection with 
intact supraglottic reflexes, would be desirable in selected groups ,such as patients with 
ischemic heart disease and raised ICP.(11) 
Various stratergies have been employed to blunt the haemodynamic responses , 
such as tracheal extubation under deeper plane of anaesthesia, exchanging an 
endotracheal tube for a laryngeal mask prior to emergence, administration of various 
drugs like lignocaine, esmolol,propofol, labetolol,fentanyl, calcium channel 
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blockers,dexmedetomidine, nitroglycerin and sodium nitroprusside. Each method has its 
advantages and disadvantages. 
1.   Extubation in deep plane of anaesthesia: “Deep” extubation, or the removal of the 
ETT while the patient is in a deep plane of general anesthesia, has been used to reduce 
cough at extubation. However, this technique is undesirable in   the patient with a 
difficult airway, gastroesophageal reflux disease, lesions with lower cranial nerve 
involvement or full stomach. Assessment of the neurologic status after extubation is not 
possible with  this method. 
2.   Exchange of an endotracheal tube for a laryngeal mask is one of the manoevers tried 
for a smooth extubation. However, this procedure involves jeopardizing a secure airway, 
that too in patients who may have coexisting diseases. Hence there is a natural hesitancy 
to perform this manoever.(1) 
 3.          Coriat et al. (17) reported that a continuous infusion of nitroglycerin (0.4 pg * 
kg-’ * min-‘1) significantly reversed or eliminated decreases in left ventricular ejection 
fraction that occurred in patients with mild angina 3 min after extubation.  
Direct vasodilators like Sodium nitroprusside and glyceryl trinitrate dilate 
cerebral vessels, increasing CBF and cerebral blood volume. Due to these unfavourable 
effects on cerebral hemodynamics, these drugs are not used in blunting hemodynamic 
responses during extubation.(31) 
4.    Beta blockers like labetolol are effective in preventing hypertension during 
intubation and emergence from anaesthesia,but has been shown to cause a high incidence 
of bradycardia in the post operative period.(32) 
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              Esmolol has also been used to attenuate hemodynamic responses to tracheal 
extubation. Dyson et al.(19)  recommended 1.5 mg/kg of IV esmolol as the best dose to 
control hemodynamic responses to tracheal extubation. Muzzi et al. (32) also found IV 
esmolol (500 pg/kg loading dose followed by a 50-300pg * kg-’ * min-’ infusion) and 
labetolol (0.25 to 2.5 mg/kg) equally effective in treating increases in blood pressure 
during emergence and recovery from anesthesia after intracranial surgery. Fuhrman et al. 
(33) compared the effects of esmolol and alfentanil on heart rate and SBP during 
emergence and extubation in a randomized double-blind investigation of 42 healthy 
patients having elective surgery. These studies demonstrate that esmolol can be used to 
control the hemodynamic response to tracheal extubation. 
  
5. The alpha agonist dexmedetomidine, a sedative and analgesic has also been 
suggested  to attenuate airway and circulatory reflexes during extubation when 
given in a single dose 0.5 micrograms/kg I.V .(34) However, hypotension and 
bradycardia are common with its use. 
6. The use of lignocaine for attenuation of extubation has been widely practiced. 
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LIGNOCAINE 
Structure 
 
 
Lignocaine is a local anaesthetic with an amide linkage between the lipophilic 
benezene ring and hydrophilic tertiary amine. 
Lidocaine alters depolarization in neurons by blocking the fast voltage gated 
sodium channels in the cell membrane. With sufficient blockade, the membrane of the 
presynaptic neuron will not depolarize and so fails to transmit an action potential, leading 
to its anesthetic effects. 
It gets metabolized by microsomal enzymes in the liver. The elimination  half life 
of lidocaine is approximately 1.5–2 hours in most patients. This may be prolonged in 
patients with hepatic impairment and in congestive heart failure .(35) 
                          Lignocaine has long been used to modulate the unwanted airway 
and circulatory reflexes seen in response to emergence and extubation. The 
administration of lignocaine has been through several routes such as  intravenous (IV) 
injection, endotracheal cuff, or intratracheal instillation.(13) 
 
 
 xxxiii
INTRAVENOUS LIGNOCAINE 
 In a study done in 1963 Steinhaus and Gaskin found that I.V 
lignocaine(1.1mg/kg) effectively suppressed cough.(36) Poulton and James also found 
that I.V lignocaine (1.5mg/kg) when compared to saline, produced significant decrease in 
the number of cough responses.(50 ).  
Wallin et al. (54) evaluated the efficacy of a continuous IV lidocaine infusion 
in attenuating the hemodynamic response perioperatively. Significant blunting of 
increases in systolic blood pressure (SBP) and heart rate were observed in patients who 
received the lidocaine infusion 5 and 10 min after extubation. 
  I.V lignocaine has been shown to be effective in depressing the cough response 
and increase in heart rate and blood pressure therefore blocking the raise in ICP during 
intubation and extubation.(3).I.V lignocaine, when given before endotracheal intubation, 
prevents arterial hypertension and tachycardia in patients with brain tumors.These actions 
appear to be mediated through the depression of brain stem neuronal activity.(24) 
 I.V lignocaine decreases CMRO2 and increases cerebrovascular resistance.Thus, 
acute lowering of ICP after lignocaine probably reflects reduction in both cerebral blood 
flow and cerebral blood volume; in a manner similar to that produced by thiobarbiturates. 
(24) Pretreatment with I.V lignocaine prevents potentially harmful rise in ICP without 
causing major changes in cardiorespiratory function or neurologic findings. Since arterial 
pressure was not affected by lignocaine treatment whereas ICP was reduced, cerebral 
perfusion was improved.  Cerebral perfusion pressure= Mean arterial pressure-ICP. 
 In addition, spontaneous ventilation and respiratory pattern will usually 
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be preserved after an IV bolus of lidocaine.  (38) 
However, intravenous lignocaine can prolong the emergence from 
anaesthesia.(13) Lidocaine inhibits neuronal transmission by its action in stabilizing the 
neuronal membrane. The central nervous system (CNS) manifestations of this may be 
excitatory and/or depressant, and the antitussive effect of IV lidocaine might be a result of 
this. However, at the doses required for this antitussive effect, there may also be other 
CNS effects.(39) In studies on dogs, Himes et al. were able to demonstrate a decrease of 
up to 28% in the minimum alveolar concentration of halothane with blood lidocaine 
levels between 3 and 10 µg/mL. Gonzales et al. (4) showed a significantly longer time to 
tracheal extubation in the group administered IV lidocaine compared with those 
administered topical lidocaine or placebo. This may also be attributable to a depressant 
effect of lidocaine on the CNS.   The efficacy of IV lidocaine in suppressing cough 
appears to be short lived.  
Yukioka et al.(40) administered IV lidocaine 1, 3, 5, 7, 10, and 15 minutes before 
endotracheal intubation and found that the incidence of cough increased gradually from 
zero percent at 1 minute to 53% at 15 minutes. The effect was consistent with a decrease 
in serum lidocaine concentrations measured at the respective times.When  the effects of 
IV lidocaine administration on cough suppression were examined, it was found  that 
complete cough suppression on tracheal intubation using IV lidocaine 2 mg/kg 1 minute 
before intubation required serum lidocaine levels >3 µg/mL.  
Studies have shown conflicting conclusions on the efficacy of intravenous lignocaine, 
which could be partly effect of varying time of injection, i.e differences in the time 
interval between administration of lignocaine and intubation.(41) Nishino et al.(42), in 
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their study on IV lidocaine and airway reflexes in anesthetized patients, also reported that 
suppression of cough reflex occurred at plasma concentrations >3 µg/mL. These studies 
show that cough suppression using IV lidocaine requires a minimal serum concentration 
for effect. Bidwai et al reported that plasma lignocaine level between 2.3 to 3 micrograms 
was needed to suppress cough at extubation.(9) 
                   Therefore, although  Intravenous lignocaine has been used for many years to 
blunt the extubation response,it has different limitations which  include : 
1. Difficulty in attaining plasma levels to suppress cough completely.Plasma lignocaine 
levels of 2.3 to 3 micrograms/ml is needed to suppress cough.(40) 
2. Short duration of action. It has a short duration of action, 5 to 20 minutes,as it is 
rapidly eliminated from the blood. This narrow antitussive window makes the optimal 
timing of administration during emergence very difficult. 
3. Systemic sedation is produced, due to which there is delay in emergence.. 
 Due to these limiting factors, the simultaneous goal of cough suppression and full 
awakening are not achieved with I.V.  lignocaine.   
 
ENDOTRACHEAL CUFF LIGNOCAINE 
Endotracheal tubes are constructed from polyvinyl chloride .The thin 
polyvinyl chloride membrane, which constitutes the tube cuff, allows simple 
diffusion of lidocaine across it and thus cause anaesthesia of the trachea. Fagan et 
al compared 4% lignocaine with saline and air in the endotracheal cuff in 63 
patients undergoing surgery. It was found the incidence of coughing was 
decreased in the lignocaine group. (11)It was suggested that the cuff could act as a 
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potential reservoir for a local anaesthetic, allowing diffusion and subsequent 
anaesthesia of the underlying mucosa. However, a similar study done by T. 
Venkatesan and G. Korula in 82 neurosurgical patients which compared 4% 
lignocaine in the cuff with 1.5 mg/kg I.V lignocaine,  showed no significant 
difference in coughing at extubation, in the two groups.(3)The administration of 
4% or 10% lignocaine through the ETT cuff may be dangerous should the cuff 
rupture as a consequence of damage.(13). 
ENDOTRACHEAL SPRAYING WITH LIGNOCAINE 
Local anaesthetics are rapidly absorbed into the circulation following topical 
administration to mucous membranes or denuded skin. Absorption is particularly rapid 
when local anaesthetics are applied to the tracheobronchial tree. Concentrations in the 
blood after instillation of local anaesthetics into the airway are nearly the same as those 
following I.V injection. 
Peak anaesthetic effect following topical application of lidocaine occurs in 2-5 
min and anaesthesia lasts for 30-45 min. Peak plasma concentrations of local anaesthetics 
depend on the amount injected,the physical charactersistics of the local 
anaesthetic,whether epinephrine is used,the rate of blood flow to the site of injection, and 
the surface area exposed to the anaesthetic.[35] 
Administration of lignocaine to the airways leads to variable plasma 
concentrations, depending on mode of delivery and dose.(43)These levels may reflect 
slow absorption from the respiratory mucosa. Lidocaine, as a weak basic and lipophilic 
drug, binds avidly to the respiratory mucosa. The absorption characteristics of the 
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mucosa, epithelial thickness, number of membrane pores, and tissue pH also serve to 
delay absorption. This intrapulmonary "depot effect" may contribute to the longer than 
expected effect of lidocaine.(39)  Both IV and topical administration of lidocaine before 
tracheal extubation have been shown to prevent coughing on emergence from general 
anesthesia (44). As with intravenous administration, the precise mechanism for topical 
effect is unclear. It may be that the primary sites of action for the two methods of 
administration are different, i.e., that topical administration is peripherally mediated and 
IV administration is centrally mediated. 
Daelim Jee et al used the administration of 1mg/kg of 2% lignocaine sprayed 
down the endotracheal tube to attenuate cough reflex.. This study was done on 3 groups 
of patients, 25 in each group. Group 1 was the control group, group 2 received 1mg/kg of 
2% lignocaine intratracheally by injection from a syringe into the endotracheal tube, 
group 3 received the same dose of 2% lignocaine IV before extubation. The results 
showed that lignocaine sprayed down the endotracheal tube suppressed the unwanted 
airway and circulatory reflexes whereas using the same dose IV lignocaine does not.(13) 
They argued that this dose would not lead to peak plasma concentrations sufficient to 
suppress the reflexes. Plasma concentrations of lidocaine required to suppress the cough 
reflex under general anaesthesia and during emergence are reported to be between 2.3 
and 3 microgram/ml.[9]     Hence they attributed the reflex suppression of endotracheal 
lignocaine to the mucosa –anaesthetizing effect.(13) 
 The study done by White et al showed that intratracheal lidocaine was more 
effective in attenuating the increase in ICP than other modalities like IV 
opioids,Thiopentone, I.V lignocaine during endotracheal suctioning.(25). 
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                            A modified endotracheal tube (ETT), the Laryngotracheal Instillation of 
Topical Anesthesia (LITA™) tube (Sheridan Catheter Corp, Argyle, NY), has been 
developed to diminish coughing during emergence from general anesthesia. This 
modified ETT contains an additional small-bore channel incorporated within the concave 
surface of the tube. Ten small holes at the distal 13 cm of the tube allow the injected 
medication to be sprayed both above and below the cuff onto the pharyngeal, 
laryngeal,and upper tracheal mucosa circumferentially.(45) 
             Gonzalez et al(11)compared topical and IV administration of lidocaine 100 mg 
before tracheal extubation using a LITA tubeTM (Sheridan Catheter Corp., Argyle, NY),  
to spray the mucosa both proximal to and distal to the inflated cuff before tracheal 
extubation and found that laryngotracheal spraying was associated with a significantly 
reduced incidence of coughing compared to placebo or IV administration. The study 
showed complete cough suppression in 36% of patients given topical lidocaine via the 
LITA™ tube as compared to 4% in control group; as well as a 50% decrease in the 
number of coughs per patient given topical anesthesia compared to control. The 
difference in efficacy may be the result of different sites of action.  
          A few reports, most in the Chinese literature, have claimed cough suppression by 
application of laryngotracheal lidocaine through the LITA™ tube in 60% to 100% 
patients.(45)However, one of the problems of this method was the fact that the tracheal 
mucosa in direct contact with the tube cuff was effectively shielded from exposure to the 
administered lignocaine.(11)Another problem was that lignocaine administration using 
LITA  tube blocked supraglottic reflexes, leading to the risk of aspiration in addition to 
the increased cost.(13) Diachun et al.(44) used a LITA to administer 2 mg/kg of 4% 
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lidocaine before tracheal extubation and also showed cough suppression on emergence.  
The maximum serum lidocaine level generated by topical lidocaine in  the study by 
Diachun was 1.62 micro_gm/mL (mean level 0.43 _microgm/mL), well below the 3 
_microgm/mL level required for IV lidocaine to prevent cough. Seventy-five percent of 
the lidocaine-treated patients were fully awake and following multiple commands without 
cough. A local effect on the laryngotrachea by spraying the mucosa would not be 
dependent on serum concentrations nor would they reflect efficacy. After endotracheal 
administration of lidocaine Diachun et al were able to show efficacy for up to 2 hours. 
This may be attributable in part to absorption characteristics after endotracheal 
administration. 
 Bidwai et al showed that tracheal administration of 60 mg of lignocaine 3-5 
minutes prior to extubation and 40 mg of lignocaine at extubation prevented increase in 
heart rate and blood pressure during and after tracheal extubation. (7) They suggested that 
as lignocaine blood levels quickly diminish following intravenous or intratracheal 
administration and topical local anaesthesia of the upper airway only lasts for 20-30 
minutes, it is important that the time of lignocaine injection be reasonably close to the 
time of extubation. 
 Yoshihiro et al showed that the cardiovascular responses in response to tactile 
airway stimulation were completely blocked by topical application of lidocaine and 
partially blocked by intravenous lidocaine. As lidocaine topically applied to the airways 
was rapidly absorbed from the airways to increase serum concentration levels ,it was 
suggested  that the action of lidocaine was partly due to its systemic effect and mainly 
due to direct blockade of the mechanoreceptors of the airways.(46) 
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Prior studies have shown that peak serum lidocaine levels, after topical administration, 
occur mainly 10 to 30 minutes after application.(47) However, Lin et al. and Wu et al. 
have obtained 77 to 100% cough suppression using topical lidocaine administered via the 
LITA™ tube 15 to 60 minutes before extubation.(45) 
              Prengel et al.(49) measured lidocaine levels after endotracheal and 
endobronchial administration. After endotracheal administration of lidocaine 2 mg/kg, 
they observed a biphasic pattern with a peak in blood concentrations occurring 
immediately after administration and a second peak between 5 and 34 minutes later. Most 
of the absorption occurred in the second delayed absorption phase, resulting in mean 
plasma levels of 1.4 µg/mL after 20 minutes.  
Yoshihiro et al showed that the cardiovascular responses in response to tactile 
airway stimulation were completely blocked by topical application of lidocaine and 
partially blocked by intravenous lidocaine. As lidocaine topically applied to the airways 
was rapidly absorbed from the airways to increase serum concentration levels,it was 
probable that the action of lidocaine was partly due to its systemic effect and mainly due 
to direct blockade of the mechanoreceptors of the airways.(46) 
A study done by Groeben and Silvanus showed that the peak plasma 
concentration of lignocaine following lignocaine inhalation was significantly lower than 
that following IV administration. Despite this  difference, both led to the same 
attenuation of bronchial hyperactivity in the study.(43)  
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Not all studies have shown favourable results with the use of endotracheal 
lignocaine for attenuating extubation response.  
A study was done on 40 patients undergoing supratentorial craniotomy by 
Andrzejowski and Francis to ascertain whether anaesthetizing the larynx with 
lignocaine would attenuate the extubation response. Lignocaine was instilled via 
the LITA tube in 20 patients, and saline was given in the other 20 patients.There 
were no statistically significant differences in hemodynamics or coughing scores 
between the 2 groups.The authors suggested that this was probably because all the 
patients in the study were betablocked – premedicated with 1mg/kg propanolol; 
so that would have attenuated the hemodynamic response.(50) 
                Kautto et al studied 48 patients scheduled for surgery ; divided them 
into 3 groups: a control group, a group receiving lignocaine aerosol, and one 
group receiving viscous lignocaine prior to induction of anaesthesia.Topical 
anesthesia was shown to attenuate pressor  response to intubation but had no 
effect on the heart rate.(51)  
Soltani and Aghadavoudi studied the effect of different lignocaine application 
methods on postoperative cough. 204 patients were divided into 6 groups. In the first 
group,10% lignocaine was sprayed ( 30mg lignocaine) on the distal end of the 
endotracheal tube and cuff, before intubation. In the 2nd group, the same dose of 10% 
lignocaine was sprayed on the laryngopharyngeal structures near the inlet of the larynx 
through a nozzle connected to the spray device during laryngoscopy. In the 3rd group the 
distal end of the endotracheal tubes and their cuffs were lubricated with  2% lignocaine 
jelly (containing 50 mg of lignocaine). For the 4th group, 1.5 mg/kg was administered 
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intravenously at the end of surgery. The 5th group got their endotracheal cuffs prefilled 
with 8 ml of 2% lignocaine for 90 minutes before intubation. In the 6th group, the distal 
end of endotracheal tubes and their cuffs were lubricated with normal saline. This study 
showed that the most efficient techniques to reduce postoperative cough were intracuff 
lignocaine and intravenous lignocaine. Topical tracheal lignocaine was not recommended 
as it was not as efficient as the previous methods  ,required a special administering 
device, and measuring the exact dose of lignocaine administered was difficult.(6) 
Jacobsen et al compared intravenous(1.5 mg/kg) with laryngotracheal(3mg/kg) 
lignocaine in patients undergoing bronchoscopy under general anaesthesia and found that 
IV lignocaine was much more effective in suppressing cough at extubation.However, the 
plasma levels exceeded the level for toxicity in 5 out of 11 patients in the IV group.(52) 
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MATERIAL AND METHODS OF STUDY 
 
After obtaining approval from the institutional ethics committee, this study was 
carried out on 114 neurosurgical patients undergoing craniotomies. 
 Inclusion criteria: 
 1. Patients undergoing elective craniotomies in the supine and lateral position with GCS 
15/15.  
2. Age 18 -65 years inclusive 
3. ASA (American Society of Anaesthesiologist) class 1 & 2  
Exclusion criteria: 
Patients with  
 1. Sore throat or active URI 
 2. History of laryngeal or tracheal pathology/surgery.  
 3. History of asthma or COPD 
  4. Requirement for postoperative ventilation 
Study Design: Prospective Randomized Double Blinded Clinical Trial. 
Location: The study was carried out in the Department of Anaesthesia in Christian 
Medical College and Hospital, Vellore. 
Sample size determination: 
The sample size was based on the study done by Daelim Jee and SoYoung Park 1 
where 3 groups of patients were assessed similarly. The means and standard deviation of 
number of coughs in the three groups were 10.2 +/-6.0, 4.5 +/-3.7, 7.8+/-4.6. With an 
alpha error of 5% and power of 80%, the sample size for each group was calculated to be 
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38. Therefore the total sample size would be 114. Sample size was determined, assuming 
that the anticipated analysis will be done using analysis of variance (ANOVA). 
 Patient allocation : 
    The patients were randomly allocated into one of the 3 groups by block 
randomization using computer assignment. The study drug was  allocated to patients 
by the pharmacy according to the block randomization done  and the nature of the 
drug was  concealed by the pharmacy.  
Patients in group 1 received  intratracheal lignocaine and intravenous placebo. 
Patients in group 2 received  intravenous lignocaine and intratracheal placebo. 
Patients in group 3 received   intravenous and intratracheal placebo (control group). 
Methodology 
 The patients were visited on the evening before the surgery, the study was 
explained  and written informed consent was obtained. Patients were premedicated with 
Valium 0.15 mg/kg. On the day of surgery, brachial central line and radial arterial line 
were started in the operating room and monitoring established with E.C.G, intraarterial 
blood pressure, pulse oximetry, temperature monitor, agent analyzer and neuromuscular 
monitor. 
 The patients were induced using Propofol 2mg/kg, Fentanyl 1-2 microgram/kg, 
along with oxygen/air/isoflurane, and paralyzed using vecuronium 0.15mg/kg. Fentanyl 
was given upto 5 micrograms/kg intra operatively, the last dose given at or before dural 
closure. Infiltration was done at the site of skin incision with saline and adrenaline at 5 
micrograms/ml. At the time of pin insertion propofol was given to attenuate the response. 
Vecuronium infusion was started before skin incision, titrated to 2 twitches on the 
 xlv
neuromuscular monitor, and stopped at the start of skin sutures. Paracetamol was given 
intravenously at a dose of 20mg/kg diluted in saline, early in the course of surgery. 
All patients were warmed using a forced-air warming blanket to obtain a central body 
temperature> 36 degrees at the end of surgery. 
Isoflurane was maintained at an end tidal concentration of 1.2 (1 MAC). At dural 
closure, sevoflurane was started and maintained at end tidal concentration of 2,and 
discontinued at the time of removal of pins at the end of surgery. After stopping 
isoflurane, gas flows were increased to 4 litres /minute. After stopping sevoflurane, gas 
flows were increased to 10 litres per minute. The study drug was given at the time of 
wound dressing both intratracheally and intravenously at a dose of 1mg/kg. 
         Neostigmine (0.05mg/kg) and glycopyrrolate (0.02mg/kg) were given for reversal 
after the removal of pins and Train of four and Double Burst Stimulation checked on the 
neuromuscular monitor. Pharyngeal suctioning and extubation were done on eye opening 
to command or when purposeful movements were observed. During this time the patient 
was not disturbed, other than a repeated verbal request (“open your eyes”).All other 
stimulation were avoided at emergence.  
The tolerance to endotracheal tube at this time was noted and smoothness of 
extubation   graded as follows.                                                                                                                             
                                                                                                                                                          
Grade 1:  No cough or coughing only during removal of endotracheal tube. 
Grade 2: Coughing while breathing regularly. 
Grade3: Coughing while not breathing regularly 
The number of coughs were also noted. 
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Coughing and hemodynamic parameters at the time of extubation and the total 
time taken for extubation were noted in all cases, starting from the time sevoflurane is 
discontinued. For a period of 5 minutes after extubation, blood pressure and heart rate 
readings were recorded. 
     The level of sedation of the patient was noted, immediately after extubation and 10 
minutes later. The following sedation score was used. 
0 –  Patient awake. 
1 – Mild   (occasionally drowsy) 
2 – Moderate (frequently drowsy) 
3 –Severe (difficult to arouse) 
 Blood samples were taken to check the plasma levels of lignocaine, 10 minutes after 
administration, and at the time of extubation. Blood was centrifuged and the separated 
plasma stored at -80 degrees, following which   plasma levels of lignocaine were assessed 
using HPLC assay. 
Statistical Analyses 
All statistical analyses were performed using SPSS (Statistical Package for Social 
Sciences) for Windows 11.0. The data was presented using descriptive statistics such as 
mean and standard deviation for continuous variables and frequency and percentage for 
categorical variables. Association  between categorical variables were assessed using chi-
square tests with Yates continuity correction. Comparison of continuous outcomes among 
groups was performed by Analyses of Variance (ANOVA). Continuous outcomes that are 
not normally distributed or ordered observations are analyzed using Kruskal-Wallis test. 
A p-value < 0.05 was considered statistically significant.  
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RESULTS AND ANALYSIS 
 
    A total of 114 patients were included in this study. There were 38 patients in each 
group. 
 Group A patients received intravenous lignocaine and endotracheal placebo. 
Group B patients received intravenous placebo and endotracheal placebo. 
Group C patients received intravenous placebo and endotracheal lignocaine. 
 
DEMOGRAPHIC DATA AND INTRA OPERATIVE VARIABLES 
 
 
  The following tables show a comparison of the distribution of patients in the 3 groups  
 
according to age, weight, gender. 
 
 Table 1 : Comparison of the demographic profile between the 3 groups. 
 
 
PARAMETER 
 
Lignocaine IV 
 
   Placebo Lignocaine  IT P value 
 
AGE    
(YEARS)         
 
    
    39±12             
     
     36±12            
       
     37±13 
 
    0.656 
 
WEIGHT   
(KG) 
 
    
   64±12 
      
     58±10           
       
    61±14 
 
    0.104 
 
MALE 
 
 
     25 
 
        20 
 
        24 
 
FEMALE 
 
      
     13 
         
        18 
         
        13 
 
 
      0.42 
 
 
Patients with a minimum age of 18 years were chosen for this study. The oldest 
patient in this study was 65   years old. The mean age of patients in group A was 39±12 
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years, group B was 36±12 years, group C was 37±13 years. There was no significant 
difference between the 3 groups with respect to age (p value of 0.656 ). 
 
The mean weight   of patients in the groups  were   64±12 kg in the 1st group, 
58±10 in the 2nd group, 61±14 in the 3rd group. There was no significant   difference with 
p value of 0.104 .The 3 groups were comparable with respect to gender also with a p 
value of   0.42. 
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The mean time intervals between the last dose of  narcotic ( fentanyl) and 
reversal, as well as the time intervals between the stopping of muscle relaxant 
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(vecuronium) and reversal were comparable in all 3 groups. The mean duration of 
surgery was also more or less similar in all groups as shown in   table 2. 
  
 
 
 
 
 
 
 
Table 2:  Comparison of mean time intervals between last dose of narcotic, muscle 
relaxant and reversal & duration of surgery.  
 
 
PARAMETER 
(Mean time interval 
in minutes) 
IV 
Lignocaine 
Placebo Intrathecal 
Lignocaine 
P value 
   
Last dose of 
narcotic  to reversal 
 
 64±41      
 
 69±37      
 
  75±37        
 
   0.53     
Stopping of vecu -
ronium infusion to 
reversal        
 
  18±7      
 
  19±10     
 
   19±12        
 
    0.56 
Mean duration of 
surgery 
 
 
  211±67 
 
  216±77 
 
  239±77 
 
   0.22 
 
 
Table 3:   Comparison between mean time intervals between last dose of each 
 
 anaesthetic drug and extubation 
   
                           
 
Mean time intervals (in 
minutes) 
 
 
IV 
Lignocaine 
 
Placebo 
 
IT Lignocaine 
 
P value 
 Last dose of  fentanyl  to 
extubation  
          
 
    80±46 
 
  84±37      
 
  91±47       
 
  0.513 
 l
 
Stopping of vecuronium 
Infusion to extubation  
   
 
   33±11        
 
 35±11       
 
  35±13         
 
  0.59 
 
 
Discontinuation of   
Isoflurane to extubation  
                           
 
   67±29 
 
   66±14 
 
  69±13         
 
   0.79 
Administration of  
study drug to extubation 
 
 
    20±9 
 
   22±6 
 
    21±7          
 
    0.69 
 
 
 
 
    The time intervals from various events as last dose of fentanyl, stopping of 
isoflurane, stopping of vecuronium infusion, and administration of the study drug   to 
extubation  were  comparable in all 3 groups. 
 
 GRADE OF COUGHING AT EMERGENCE 
Grade 1: No cough or coughing only during removal of endotracheal tube. 
Grade 2: Coughing while breathing regularly. 
 
Grade 3: Coughing while not breathing regularly 
 
 
 All patients in the IV group had only either grade 1 or 2 cough.  Patients in the other 
groups had grade 3 cough as well. 
Even though most patients had only grade 1 cough in the intratracheal group, this 
difference was found to be not statistically significant (p value of 0.13). 
 
Table 4 :  Comparison between grading of extubation between the three groups  
 
 li
 
 
GRADE OF 
COUGH            
 
 
IV LIGNOCAINE 
 
PLACEBO 
 
IT LIGNOCAINE 
 
P value 
 GRADE l    
                    
         20        19          25 
GRADE 2 
 
         18         17           9 
GRADE 3 
 
          0          2           3 
 
 
  0.13 
 
 
 
 
 
 
 GRADES OF EXTUBATION IN THE 3 GROUPS 
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There was no statistically significant difference in the number of coughs at extubation,in 
the 3 groups.(Chi square value of 2.36). 
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Table 5: No of coughs in the 3 groups 
 
 
 
PARAMETER 
 
 
LIGNOCAINE 
IV      
 
PLACEBO 
 
LIGNOCAINE 
IT 
 
P VALUE 
 
MEAN NO: OF 
COUGHS         
  
     4.7±4.3 
   
   4.3±3.3            
 
   3.49±3.3     
 
   2.36 
 
 
 
 
 
 
 
 
HEMODYNAMIC PARAMETERS. 
 
Table 6: Heart rate measured over a period of 5 mins after extubation compared 
with baseline and pre-extubation values 
         
 
GROUP 
 
 
Baseline 
At 
Study 
drug   
 
Pre 
extbn   
 
                       Post extubation 
1 min        2 min       3 min     4 min    5 min     
                                                                   
    
IV  
  
            
 
83±10      
 
88±20   
 
87±20   
 
96±20   
 
95±21   
 
95±21   
 
93±19 
 
94±20
 
PLACEBO 
 
 
 
 85±10     
 
94±13   
 
94±14   
 
101±14 
 
100±13
 
100±15 
 
98±15 
 
99±14
   
IT  
           
 
83±11      
 
93±15   
 
93±15   
 
101±17 
 
97±18  
 
93±17    
 
93±18 
 
93±19
 
P value     
    
 
0.47          
 
0.27       
 
0.20       
 
0.32        
 
0.45       
 
0.24       
 
0.31      
 
0.33     
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The baseline heart rate was comparable in 3 groups. The arithmetic mean of 
baseline heart rate  IV group was 83±10 ,for placebo 85±10, for ET group 83±11. 
There were no significant differences in the mean heart rate measured at various time  
 
points before and after extubation.    
 
 
 
 
 
 
 
HEART RATE MEASURED OVER A PERIOD OF 5 MINUTES AFTER  
 
EXTUBATION COMPARED WITH BASELINE AND PRE EXTUBATION  
 
VALUES 
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There were no significant differences in the mean blood pressure between the 3 
groups.The use of lignocaine either intravenously or intratracheally did not significantly 
attenuate the cardiovascular responses to extubation. Table 7 shows the mean blood 
 liv
pressure measured over a period of 5 minutes after extubation compared with baseline 
and pre-extubation values. 
 
 
 
 
 
Table 7: Mean blood pressure measured over a period of 5 mins after extubation 
compared with baseline and pre-extubation values 
   
Group Baseline Study 
drug   
Pre 
extubation
Post 
extubation
1 min 
Post 
extubation
2 min 
Post 
extubation 
3 min 
Post 
extubation
4 min 
Post 
extubation
5 min 
   IV 
 
 
 
95±9     
 
76±12  
 
  78±10 
 
97±14    
  
98±15    
 
97±15   
 
95±15   
 
95±15 
 
Placebo 
 
93±10   
 
71±12  
 
  79±11 
 
91±16     
 
91±16   
 
90±12   
 
90±13   
 
90±13 
 
 
IT 
 
93±10    
 
75±12  
 
76±12 
 
97±15    
 
96±15   
 
97±15   
 
96±14   
 
95±14 
 
 
P 
Value 
 
0.39 0.23 0.72 0.21 0.12 0.07 0.18 0.17 
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TOTAL TIME TAKEN FOR EXTUBATION  
 
  The total time taken for extubation,i.e the time from discontinuation of sevoflurane to 
the removal of the endotracheal tube was as follows: 
Table 8: Total time taken for extubation 
 
 
PARAMETER 
                            
I.V 
LIGNOCAINE   
 
PLACEBO 
 
I.T 
LIGNOCAINE   
 
p value 
Time in 
minutes               
 
17±8.5 
 
 
18±5.6           
 
17.9±7.7 
 
0.843 
 
There was no significant difference in the total time taken for extubation in the 3 groups. 
The administration of lignocaine intravenously or endotracheally did not delay 
awakening in these groups. 
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SEDATION SCORE  
 
The level of sedation of the patient was noted, immediately after extubation and 10 
minutes later. The following sedation score was used. 
1 – Patient awake. 
2 – Mild   (occasionally drowsy) 
3 – Moderate (frequently drowsy) 
4 –Severe (difficult to arouse) 
The sedation scores immediately after extubation and 10 minutes later were not 
significantly different between groups.This suggests that there is no increase in sedation 
with the use of lignocaine, either intravenously or intratracheally, as compared to 
placebo. 
 
 
Table 9 : Sedation score immediately  after extubation. 
 
  
 
SEDATION      
SCORE 
 
I.V 
LIGNOCAINE   
PLACEBO I.T 
LIGNOCAINE 
p value 
  1(awake) 
 
       3        4        6 
  2(mild) 
 
     10        8        4 
  3 (moderate) 
 
     15         4         17 
 
   4(severe) 
 
    
     10 
   
        8 
   
       10 
 
 
 
 
       0.65 
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Table 9 : Sedation score 10 minutes  after extubation. 
 
 
 
SEDATION      
SCORE 
 
I.V 
LIGNOCAINE   
PLACEBO I.T 
LIGNOCAINE 
p value 
   1(awake) 
 
    10        10            9 
    2(mild) 
 
     15      13         14 
    3 (moderate) 
 
     11      12          10 
 
   4(severe) 
 
    
     2 
   
       3  
   
        4 
 
 
 
 
       0.98 
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SEDATION SCORES 10 MIN AFTER EXTUBATION
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Table 10: Mean Plasma levels of Lignocaine in mcg/ml 
 
Mean Plasma 
levels (mcg/ml) 
 
 
Lignocaine 
     I.V 
 
Placebo 
 
Lignocaine IT 
 
   P value 
 
AT 10 MIN  
                             
 
0.84+/-0.8            
 
 
  0.07+/-0.3 
 
    0.88+/-0.8 
 
 
 
   <0.001 
AT 
EXTUBATION     
 
 
0.63+/-0.7            
 
   0.03+/-0.3 
 
    0.79+/-0.6 
 
 
    < 0.001 
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The plasma levels of lignocaine were similar in groups given intravenous and 
intratracheal lignocaine.The mean plasma levels were 0.84 micrograms/ml and 0.63 
micrograms/ml for I.V  and 0.88 mcg/ml and 0.79mcg/ml for intratracheal, respectively 
at 10 min after the study drug and at extubation. 
 
 
 
Table 11: Maximum Plasma levels of Lignocaine in mcg/ml 
 
Maximum Plasma 
levels (mcg/ml) 
 
 
Lignocaine 
     I.V 
 
Lignocaine IT 
 
   P value 
 
AT 10 MIN  
                             
 
    4.82 
 
       4.69    
 
   <0.001 
AT 
EXTUBATION      
 
 
     4.25                    
 
        2.74 
 
 
    < 0.001 
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                 The maximum values in the I.V group were 4.82 mcg/ml and 4.25 mcg/ml, and 
in the intratracheal group were 4.69 mcg/ml, and 2.74 mcg/ml respectively. Very few 
patients had plasma levels of lignocaine sufficient to attenuate the extubation response - 
only 3 patients had plasma lignocaine levels greater than 2.3micrograms/ml 10 minutes 
after the study drug was given, of which two were given I.V lignocaine and one was 
given intratracheal lignocaine. At the time of extubation, only 2 patients from the 
intratracheal group and 1 patient from the I.V group had plasma levels higher than 2.3 
micrograms/ml.                       
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DISCUSSION 
 
      Smooth extubation and suppression of emergence response are extremely important 
in neurosurgical patients. This randomised double blind study was done to find out if 
administering lignocaine in a dose of 1 mg/kg through the endotracheal tube would 
decrease emergence response and if this would have any advantage over the intravenous 
route in patients undergoing craniotomies.  
              All patients were comparable with regard to age, body weight and gender. All 
patients in the study were anaesthetized with a uniform anaesthetic protocol. We 
maintained anaesthesia with fentanyl, vecuronium infusion, and isoflurane at a 
concentration of 1 MAC. We chose 1 MAC isoflurane for maintenance in order to 
prevent awareness especially as nitrous oxide was avoided in the anaesthetic protocol.  
Using isoflurane with semiclosed system and low flows till pin removal could cause 
delay in patient awakening and could be a confounding factor in assessing sedation 
caused by lignocaine. Therefore during dural closure, we discontinued isoflurane and 
switched over to 1 MAC sevoflurane. Sevoflurane was continued till the end of surgery 
i.e. till the pins were removed in all patients and so a uniform end point of 
discontinuation of volatile agent was maintained for all. 
      We used an infusion of vecuronium with neuromuscular monitoring and aimed at 2 
twitches on Train of four stimulation  for uniform maintenance of neuromuscular 
blockade in all patients. The vecuronium infusion was stopped at the start of skin closure 
and neuromuscular blockade reversed at pin removal. There was no fade obtained with  
Train of four stimulation or Double Burst Stimulation in any patient before extubation. 
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We looked at the time intervals between various events during anaesthesia, such as 
interval between last dose of fentanyl and reversal, stopping of vecuronium infusion and 
reversal, as well as time from stopping of isoflurane to extubation, etc. The time intervals 
in all 3 groups were almost identical. This was possible as we followed a standardized 
anaesthetic protocol in all patients.  
Our main objectives of this study were to find out  
1. If lignocaine at dose of 1mg/kggiven intratracheally  has any suppressive effect on 
extubation response 
2. To try to ascertain the mechanism of action of tracheal instillation ( local mucosal 
anaesthesia/ systemic effect) 
3. If lignocaine in the dose used intratracheally or intravenously caused any delay in 
awakening  
The parameters we used were cough response (the number of cough as well as the grade 
of cough), the hemodynamics and sedation score.  
To assess the smoothness of extubation, several studies have assessed the number of 
coughs at extubation.(6)  Jee et al (13) in their study found that the number of coughs 
were significantly  less in the patients given lignocaine via the intratracheal route  as 
compared to intravenous or placebo. Our study showed that the number of coughs were 
not significantly different in the intravenous or intratracheal route as compared to the 
placebo group.  
We also graded the cough during extubation depending on the time of first appearance of 
cough as was done in a previous study by T.  Venkatesan and G. Korula (3) in 
neurosurgical  patients. A patient who coughs prematurely before attaining regular and 
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adequate  respiration cannot be extubated and  is at a greater risk of complications such as 
intracranial hematoma and raised intracranial pressure. However,there was no difference 
in the grade of cough in the 3 groups. Our results also show that more than half the 
number of patients had no cough or coughed only at the time of removal of endotracheal 
tube (grade 1). Only 5 patients (out of 114) had grade 3 cough. We attribute this to 
adequate reversal of muscle relaxation before awakening and maintenance of sevoflurane 
till pin removal with good analgesia ( upto 5 micrograms/kg of fentanyl and paracetamol 
(20mg/kg)  
    Local anaesthetic, as its name suggests, is taken up by the local nerve endings and is 
responsible for its local action. We hypothesized that if a significant dose is taken up 
locally, the amount absorbed would be less with a lower serum concentration in the 
intratracheal group and hence less side effects. As one of the described drawbacks of 
using lignocaine is the sedation it causes, we looked for delayed awakening from 
anaesthesia in the group which received lignocaine intravenously. However we did not 
find any difference between the groups. The dose of lignocaine we used was 1mg/kg 
(Astra Zeneca) as was used by Jee et al(13) .Our results did not agree with their result 
which showed the intratracheal route to be superior to intravenous route and placebo. We 
found no difference in extubation time between the 3 groups. We measured the plasma 
lignocaine levels in all the patients. The serum level of lignocaine at 10 minutes after 
administration of the study drug in the placebo group was 0.07 microgram/ml and in the 
two lignocaine groups were  0.84 µgm/ml  for intravenous(IV) and  0.88 µgm/ml for 
intratracheal(I.T). Though the level of lignocaine in the IT and IV groups were 
significantly higher than the placebo group,  the serum levels in both groups were much 
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lower than the reported concentration needed to suppress extubation response. There was 
no significant fall in plasma levels at the time of extubation also between the two 
lignocaine groups. The recommended plasma lignocaine level for attenuation of the 
cough  response  is >2.3 micrograms/ml. Only 3  out of 114  patients reached this level . 
Jee et al(13) did not measure plasma levels in their patients.  
            The sedation score immediately after extubation was uniformly higher than 
optimal in all the groups. There were 28 patients who had a sedation score of 4 ( difficult 
to arouse) at extubation. This was seen in all the three groups. However at 10 minutes 
after extubation the number of patients with a  sedation score of 4 had come down to 9. 
We kept the anaesthetic till pin removal as this is the time when the cough usually 
appears in a lightly anaesthetized patient. No patient including those in the placebo group 
coughed at this point. Perhaps if we had stopped the anaesthetic at an earlier period, or 
had used a lower concentration 0.8 MAC which is considered adequate to prevent 
awareness (53), we may have had a lesser sedation score. The time of administration of 
the study drug (I.V lignocaine, intratracheal lignocaine or placebo ) was at the time of 
placing the wound dressing .Although there is a difference in the time of peak action with  
intravenous  and intratracheal route, we kept this time of administration in order to ensure 
blinding of the study. The half life of lignocaine when given intravenous  is 8 minutes, 
but the peak effect after intratracheal administration is at 10 to 30 minutes. (44,46,47) We 
estimated an approximate time of 10 minutes for extubation from the point of 
administration of the study drug.. However, our patients could be   extubated,  only on an 
average time of    20 minutes after the drug administration. Though the extubation time 
was prolonged, we estimated the serum level of lignocaine at 10 minutes and at the time 
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of extubation and found no difference in the IT and IV group. In the tracheal group if the 
effect was by local action, we would have found a lower sedation score. On the other 
hand if absorption from the tracheal route is as fast as intravenous, there would be no 
difference between the groups. There was no difference in the concentration at both time 
points suggesting a rapid absorption of lignocaine from the tracheal route. In our study, 
we found that the average sedation score was very similar in all three groups 
substantiating the fact that lignocaine in that concentration does not cause undue 
sedation. 
          In neurosurgical patients a rise in blood pressure and heart rate can cause 
detrimental rise in intracranial pressure which can adversely affect the postoperative 
outcome. Hence in our study the hemodynamic response to extubation was assessed by 
recording the heart rate and blood pressure values at various time points before and after 
extubation. It was found that the use of lignocaine intratracheally did not significantly 
attenuate the cardiovascular responses to extubation. We also found that most patients, 
irrespective of the group to which they belonged, did not have high blood pressure values 
in response to extubation. 
Our study showed that using lignocaine at a dose of 1 mg/kg intravenously and via 
tracheal instillation  20 minutes prior to extubation, did not have any advantage in 
suppressing cough response and haemodynamic changes over a carefully given 
anaesthetic  and a slow gradual awakening.  What surprised us was the serum level 
measured with a dose of 1 mg/kg was much lower than the required plasma level for 
suppression of extubation response.  
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LIMITATIONS 
 
 
1. In this study, as per our standardized anaesthetic protocol, we used 1 MAC of  volatile 
anaesthetic for all patients which was discontinued only at the time of pin removal. This 
may have been too high for us to assess emergence response because many of our 
patients were sedated at the time of extubation. Studies have suggested that 0.8 MAC of 
volatile agent is sufficient to prevent awareness during surgery.(52) 
2. The mean plasma level of lignocaine obtained was 0.8 micrograms/ml, which was 
inadequate to suppress extubation response. Probably our time of administration of the 
study drug was too early or the dose administered was suboptimal. We had chosen this 
particular dose as per a previous study(13) which showed a significant suppression of 
airway and circulatory reflexes. Jacobsen et al when using 1.5 mg/kg had found toxic 
levels of lignocaine in 5 out of 11 patients (51).   Prengel et al in their study using 
intratracheal lignocaine found that there were two peak levels of absorption with this 
route (48) and we  did not want our patients to have a high concentration after extubation 
when the anaesthetist is not constantly monitoring the patient . The half life of lignocaine 
is 8 minutes and the duration of action of topical lignocaine lasts up to 30 minutes(34). 
We chose a time of 10 min to enable blinding of the study. However we could extubate 
our patients only by about 20 min. Perhaps the concentration after intravenous dose had 
waned by this time but the action of topical lignocaine should have still been present.  
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CONCLUSIONS 
 
 1.  Lignocaine in the dose of 1 mg/kg given intratracheally does not prevent cough or 
hemodynamic response at emergence if given 20-30 min prior to extubation. Lignocaine 
in this dose provides poor local anaesthetic effect after tracheal instillation.   
  2.  There was no increase in sedation with the use of lignocaine at a dose of 1 mg/kg 
when administered 20-30 min before extubation. 
  3.  When volatile agents such as isoflurane and sevoflurane are continued till pin 
removal with an adequate dose of fentanyl, cough and haemodynamic response to 
extubation   can be suppressed but with higher sedation in neurosurgical patients.  
  4.   Plasma level of 0.8 µgm/ml was not sufficient to suppress cough at extubation.  
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PATIENT INFORMATION SHEET                  
STUDY NO: 
TITLE OF THE STUDY: 
 Instillation of lignocaine down the endotracheal tube to reduce extubation response in 
comparison with intravenous lignocaine and placebo in neurosurgical patients. 
 
INSTITUTION: Department of Anaesthesia, Christian Medical College and Hospital. 
 
NATURE AND PURPOSE OF THE STUDY:  
The purpose of this research project is to assess the efficacy of intratracheal lignocaine in 
reducing cough at the end of anaesthesia.          
     You are going to undergo a major neurosurgical procedure. To give you anaesthesia, we 
will first put you to sleep with intravenous drugs and then insert a tube into your throat 
through which anaesthetic gases will be given to keep you asleep and unconscious. At the 
end of the surgery, we will remove the tube from your throat and wake you up. This phase is 
usually associated with coughing, increase in blood pressure, heart rate and if it occurs can be 
harmful to the patient following a major procedure. To prevent this, different drugs like 
intravenous opioids, beta blockers and lignocaine have been investigated without any 
conclusive evidence supporting one. Intravenous Lignocaine is used for this purpose with 
beneficial effect but the time taken for the patient to wake up may be delayed. We are doing 
this study to see if lignocaine given through the tube will hasten your recovery.  
If you are willing to take part in the research project, you will be randomly allocated to one 
of the 3 groups. One group will receive the study drug intratracheally, 2nd group will receive 
the study drug intravenously, and the 3rd group will receive a placebo drug. The response to 
the drug will be assessed and recorded. The level of the study drug in the blood will be   
evaluated. The amount of blood that will be taken from you for this purpose will be very 
minimal. The day after surgery, you will be interviewed about sore throat.   
 
RISKS OF THE STUDY: 
                    There are no additional risks anticipated from your participation in the study. 
 
EXPECTED DURATION OF INVOLVEMENT:  
On the day of surgery and one day post operatively.         
 
BENEFITS OF THE STUDY:  
The outcome of the study will help us to know whether intratracheal lignocaine is 
beneficial in reducing extubation response.        
                               
 CONFIDENTIALITY:  
All personal details identifying you will be kept confidential and only data relevant to 
the study will be stored and analyzed. 
 
SUBJECT’S INITIALS:                                                      SUBJECT’S NAME: 
 
DATE OF BIRTH /AGE: 
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 INFORMED CONSENT FORM 
 
Please  initial  the correct box: 
 
(i)I confirm that I have read and understood the information sheet dated _________ for 
the above study and have had the opportunity to ask questions. [ ]  
 
(ii) I understand that my participation in the study is voluntary and that I am  
   free to withdraw at any time, without giving any reason, without my medical care                     
or legal rights being affected. [ ]  
 
(iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission 
to look at my health records both in respect of the current study and any further research 
that may be conducted in relation to it, even if I withdraw from the trial. I agree to this 
access. However, I understand that my identity will not be revealed in any information 
released to third parties or published. [ ]  
 
(iv) I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s) [ ]  
 
(v) I agree to take part in the above study. [ ]  
 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
 
Date: _____/_____/______ 
  
Signatory’s Name: _________________________________  
 
Signature of the Investigator: ________________________  
 
Date: _____/_____/______  
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PATIENT PROFORMA                                                                     
                                                                                                    SERIAL NUMBER 
 
NAME    :                                      AGE:                               HOSPITAL NUMBER: 
GENDER : M  /  F                         WEIGHT: 
UNIT/WARD:                                 ASA GRADE : 1 / 2 
 
SURGERY: 
COMORBID ILLNESS: 
DATE  OF  SURGERY: 
DURATION  OF  SURGERY:               am  /pm    TO                         am/pm 
 
TOTAL DOSE OF FENTANYL:  
 
                                     EVENT                                                                    TIME 
    
 LAST DOSE OF FENTANYL                      ( at dural closure or earlier)    
 
 STOPPING ISOFLURANE                          :(at dural closure) 
 & STARTING SEVOFLURANE 
 
 STOPPING  VECURONIUM INFUSION      (at time of skin suture)  
 ADMINISTRATION OF STUDY DRUG      (at wound dressing)  
STOPPING SEVOFLURANE                        (at pin removal)    
 ADMINISTRATION OF REVERSAL          (after pin removal):  
TIME OF EXTUBATION: 
 
 
: 
 
SMOOTHNESS OF EXTUBATION : 1/2/3 
Grade 1: no cough or coughing only during removal of endotracheal tube. 
Grade 2: coughing while breathing regularly. 
Grade3:  coughing while not breathing regularly 
                                                                                                                                                                                                
NUMBER OF COUGHS DURING EXTUBATION: 
 
TIME OF BLOOD SAMPLING:.A-10 min after study drug: 
                                                      B- At extubation 
                                                                                                                                                                                                
SEDATION SCORE AT EXTUBATION: 
 Immediate: 
After 10 min: 
At transfer:     
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               Blood pressure 
Systolic           diastolic           mean 
 
 
saturation 
 
 
Pulse rate 
Baseline 
(in the ward) 
   
   
At 
administration 
of study drug 
     
Pre 
extubation(after 
pin removal) 
     
Post extubation 
1 minute 
     
2 minutes      
3 minutes      
4 minutes      
5 minutes      
 
 
 
 
SERUM LEVEL OF THE STUDY DRUG 
 
 Sample A (10 min after study drug) 
 
 Sample B (at extubation) 
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ABBREVIATIONS IN DATA SHEET 
 
T.F.E: Total time taken for extubation (stopping sevoflurane till removal of endotracheal tube) 
 
Grade: Grade of cough at extubation 
 
Sed 0: sedation score at time of extubation 
Sed1: sedation score 10 minutes after extubation 
 
B.SBP: Baseline systolic blood pressure            
B.DBP: Baseline diastolic blood pressure  
B.MBP: Baselinemean blood pressure                                                                                                               
B.HR:  Baseline heart rate   
                                       
SD.SBP:  Systolic blood pressure at study drug administration   
SD.DBP: Diastolic blood pressure at study drug administration   
SD.MBP: Mean blood pressure at study drug administration   
SD.HR: Heart rate at   study drug administration   
                                                         
Pre.SBP : Pre extubation systolic blood pressure 
Pre.SBP: Pre extubation diastolic blood pressure 
Pre.MBP: Pre extubation Mean blood pressure 
Pre HR: Pre extubation heart rate 
 
P1.SBP: Post extubation systolic blood pressure (1 minute after extubation) 
P1.DBP: Post extubation diastolic blood pressure (1 minute after extubation) 
P1.MBP: Post extubation mean blood pressure (1 minute after extubation) 
P1 HR: Post extubation heart rate (1 min) 
 
 
P2.SBP: Post extubation systolic blood pressure (2 minutes after extubation) 
P2.DBP: Post extubation diastolic blood pressure (2 minutes after extubation) 
P2.MBP: Post extubation mean blood pressure (2 minutes after extubation) 
P2 HR Post extubation heart rate (2 min) 
 
P3.SBP: Post extubation systolic blood pressure (3 minutes after extubation)  
P3.DBP: Post extubation diastolic blood pressure (3 minutes after extubation) 
P3.MBP: Post extubation mean blood pressure (3 minutes after extubation) 
P3 HR: Post extubation heart rate (3 min) 
 
P4.SBP: Post extubation systolic blood pressure (4 minutes after extubation) 
P4.DBP: Post extubation diastolic blood pressure (4 minutes after extubation) 
P4.MBP: Post extubation mean blood pressure (4 minutes after extubation) 
P4 HR: Post extubation heart rate (4 min) 
 
P5.SBP: Post extubation systolic blood pressure (5 minutes after extubation) 
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P5.DBP: Post extubation systolic blood pressure (5 minutes after extubation) 
P5.MBP: Post extubation mean blood pressure (5 minutes after extubation) 
P5 HR: Post extubation heart rate (5 min) 
 
Fe-Ex: Time interval from last dose of fentanyl to extubation 
Fe-Rev: Time interval from last dose of fentanyl to reversal 
 
Vec-Ex: Time interval from stopping of vecuronium infusion to extubation 
Vec-Rev: Time interval from stopping of vecuronium infusion to reversal 
 
Sd-Ex: Time interval from administration of study drug to extubation 
Iso-Ex: Time interval from stopping of isoflurane to extubation 
 
Plasma 1: Plasma level of lignocaine 10 min after study drug administration 
Plasma 2: Plasma level of lignocaine at extubation 
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hosp.no age weight gender duration 
serial 
no T.F.E grade 
no: 
cough      sed 0 sed10 
192487d 39 86 m 175 2 30 2 5 2 1
189060d 63 63 f 330 3 26 1 3 2 1
m 196698d 25 51 m 135 4 17 2 10 1 0
s 197050d 19 55 m 310 5 18 2 5 2 1
ri 189448d 43 60 f 270 6 11 1 3 2 1
178491d 43 60 m 180 7 17 1 2 2 2
a 198598d 48 72 m 191 8 17 2 8 2 2
h 191504d 20 40 f 240 9 22 3 10 1 0
ni 166435d 56 66 m 250 10 9 1 4 2 1
ar 193332d 38 59 m 300 11 13 1 1 2 1
193623d 29 46 m 180 12 26 1 2 2 1
r 201551d 35 48 f 120 13 27 1 0 0 0
e 197921d 43 43 f 230 14 21 1 3 2 2
ma 639425c 27 48 f 320 15 17 1 0 0 0
187186d 43 80 m 185 16 20 2 6 2 2
i 200693b 35 49 f 300 17 7 1 2 2 1
204773d 31 47 f 180 18 15 1 0 2 1
199805d 42 60 m 330 19 27 3 10 2 1
208075d 35 60 f 232 20 7 2 6 2 2
992038c 39 88 m 180 21 17 1 5 2 1
204723d 62 60 m 283 22 30 1 0 2 1
213989d 52 63 m 220 23 22 2 7 1 1
m 158764d 64 51 m 203 24 14 1 3 2 1
           
162975d 37 58 m 270 26 31 1 1 2 1
217753d 18 84 f 335 27 16 1 2 2 2
188213 36 69 f 290 28 25 3 10 0 0
159898d 44 75 m 195 29 17 1 3 2 1
213561d 37 85 m 215 30 48 1 4 2 2
221015d 18 49 m 156 31 8 2 7 3 2
223475d 20 63 m 440 32 21 1 2 1 1
227326d 48 72 m 218 33 27 2 6 2 1
224955d 43 65 m 90 34 12 1 1 0 0
219327d 24 66 m 180 35 17 2 8 2 1
217009d 53 64 f 300 36 21 3 9 2 2
233592d 56 76 m 90 37 11 1 1 1 0
ge 236628d 41 82 m 240 38 14 2 7 2 1
206886d 32 82 m 75 39 7 2 10 1 0
221688d 28 52 f 205 40 14 1 1 0
0 
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B. SBP B.DBP B.MBP B.HR 
SD. 
SBP SD.DBP SD.MBP SD.HR Pre.SBP Pre.DBP Pre.MBP Pre.HR
110 80 90 80 114 78 90 103 108 71 83 102
140 90 107 80 98 53 66 106 106 61 78 110
106 60 75 90 105 55 71 110 111 60 75 112
130 80 97 80 120 72 88 106 120 71 89 100
120 70 87 88 122 73 92 101 123 70 91 103
130 90 103 78 101 64 78 83 108 62 79 90
130 80 97 82 93 63 75 82 104 69 83 90
110 80 90 80 130 93 106 106 122 84 105 87
140 100 113 84 92 57 70 109 109 63 78 118
140 90 107 92 94 53 67 122 99 53 69 128
134 80 98 120 106 61 71 101 104 51 70 80
108 77 87 79 107 75 90 80 122 87 102 81
110 70 83 100 93 54 70 93 101 57 75 86
100 68 79 98 79 46 60 116 89 54 69 121
130 90 103 80 109 68 84 80 92 55 69 72
126 86 99 83 102 50 69 100 110 51 71 110
110 76 87 83 109 60 76 91 122 64 85 97
104 68 80 78 103 58 71 105 95 52 67 102
120 80 93 86 112 50 74 111 116 50 72 108
140 90 107 72 108 62 78 95 105 60 76 85
110 76 87 78 102 55 70 80 154 74 101 81
110 92 98 96 114 71 89 74 125 78 98 73
150 80 103 64 139 77 104 77 130 68 94 81
  0          
114 68 83 70 89 42 55 84 137 58 82 85
120 90 100 90 124 78 94 106 131 71 88 103
140 90 107 88 121 76 94 97 113 63 81 89
140 90 107 84 100 60 74 82 123 64 89 81
140 90 107 94 108 73 87 88 109 76 90 86
130 90 103 102 103 57 73 133 132 73 93 139
100 70 80 82 114 67 83 119 138 87 102 128
140 80 100 101 120 81 98 95 120 77 95 94
140 80 100 90 120 75 95 78 123 74 94 77
120 80 93 72 108 66 97 89 115 67 82 80
130 90 103 88 91 40 57 80 120 53 74 111
120 90 100 92 115 57 77 77 133 62 86 78
120 90 100 84 122 75 90 103 126 85 108 94
110 60 77 80 117 66 83 109 119 66 86 114
140 80 100 88 92 60 73 106 109 66 87 85
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Pre.MBP Pre.HR P1SBP P1DBP P1MBP P1HR P2SBP P2DBP P2MBP P2HR P3SBP P3DBP 
83 102 131 83 101 102 127 82 98 103 130 82
78 110 122 84 65 110 109 56 68 112 114 68
75 112 120 68 85 133 115 63 80 126 116 62
89 100 137 84 106 89 136 79 102 91 126 72
91 103 125 72 92 102 128 77 97 102 145 92
79 90 147 83 106 102 158 87 111 102 151 81
83 90 156 88 118 87 164 91 122 88 168 92
105 87 137 92 109 103 160 98 119 87 139 97
78 118 124 69 91 126 138 81 101 124 136 80
69 128 131 88 103 128 127 82 98 129 123 80
70 80 116 59 83 108 119 63 86 112 117 61
102 81 166 98 127 89 164 97 124 90 160 96
75 86 122 70 94 94 102 65 82 99 114 70
69 121 120 69 86 119 112 70 107 119 103 68
69 72 115 64 82 90 138 83 106 139 139 84
71 110 112 58 77 112 112 59 78 110 113 59
85 97 115 65 86 104 118 63 85 93 122 61
67 102 158 75 103 106 147 71 97 104 146 73
72 108 154 66 99 112 136 58 87 114 139 59
76 85 127 70 91 90 124 70 90 90 135 82
101 81 178 93 127 92 177 92 124 87 175 90
98 73 144 77 101 79 154 78 104 79 160 77
94 81 132 71 100 82 145 74 106 80 149 75
            
82 85 141 70 93 80 126 58 80 89 128 58
88 103 164 92 113 121 147 83 107 114 156 86
81 89 135 88 101 107 125 75 98 98 122 70
89 81 122 67 87 75 106 61 77 69 111 59
90 86 132 82 102 89 127 73 94 88 139 81
93 139 140 76 99 137 135 78 101 145 140 80
102 128 134 81 97 130 133 81 97 120 143 84
95 94 147 91 110 91 153 100 118 91 154 99
94 77 145 90 83 75 165 93 126 90 147 87
82 80 143 81 99 94 122 70 88 99 130 69
74 111 152 72 98 112 118 65 84 111 125 65
86 78 200 90 128 90 171 81 116 90 150 77
108 94 123 80 95 99 129 86 105 90 138 86
86 114 137 80 98 121 135 75 95 115 126 73
87 85 115 70 90 102 123 75 95 102 121 72
85 76 165 112 132 82 181 136 140 87 157 107
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P3MBP P3HR P4SBP P4DBP P4MBP P4HR P5SBP P5DBP P5MBP P5HR Fe-Ex Fe-Rev 
100 102 129 79 98 102 129 81 98 103 115 86
87 118 130 68 93 102 116 65 82 115 122 118
79 126 119 64 82 126 114 58 77 128 61 45
93 104 129 75 97 92 125 76 96 90 115 99
124 106 123 78 93 113 129 72 94 114 56 47
106 102 151 81 106 102 145 79 101 102 40 25
124 85 164 89 121 84 163 89 122 84 58 42
105 100 130 87 108 84 129 89 107 92 109 87
99 123 134 77 97 127 136 80 95 122 85 76
98 123 139 80 102 134 131 78 100 131 70 59
84 112 119 59 82 112 123 60 83 110 96 77
123 86 152 96 120 86 150 93 118 85 66 39
89 83 120 69 92 78 118 68 91 76 70 52
82 119 112 69 85 115 106 63 82 117 32 17
103 145 136 80 104 74 134 82 101 72 182 163
79 110 114 60 80 109 116 61 79 108 32 27
84 89 120 60 82 87 117 59 81 82 60 45
97 100 145 72 97 96 140 69 94 95 73 45
89 114 135 58 86 114 137 58 85 113 27 30
101 89 130 71 93 89 130 68 89 88 77 61
124 90 173 88 122 81 170 85 119 81 40 14
106 85 161 79 107 86 160 77 105 86 54 33
108 80 151 75 109 78 149 74 107 76 217 204
            
81 85 128 58 80 84 132 52 82 82 101 73
111 112 157 81 101 103 154 80 107 118 125 110
90 101 123 70 90 91 133 76 101 81 215 190
76 69 150 63 81 65 117 63 83 83 75 64
102 87 129 73 94 84 125 74 95 81 193 145
102 139 140 77 100 135 147 74 100 132 58 50
104 118 144 87 106 118 137 86 104 118 119 101
124 89 157 96 122 90 149 93 119 89 223 200
104 90 144 82 100 87 149 76 106 89 100 88
88 78 135 76 96 79 130 72 90 98 50 33
86 111 140 67 90 110 143 67 92 109 187 168
107 87 169 78 114 87 170 78 113 86 68 60
107 91 116 79 91 96 107 78 89 95 98 86
93 112 143 76 100 110 137 77 97 112 54 47
90 99 126 67 93 99 125 75 94 102 79 67
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Fe-Ex Fe-Rev Vec-Ex 
Vec-
Rev Sd-Ex Iso-Ex Plasma1 plasma2 code 
115 86 42 13 33  0.7  A 
122 118 47 23 29  0  B 
61 45 24 8 22  0.57  A 
115 99 30 14 18  0  B 
56 47 31 22 15  0  C 
40 25 30 15 20  0.308  A 
58 42 23 7 19  1.06 0.86 C 
109 87 33 11 27  0 0 B 
85 76 20 11 15  0.86  A 
70 59 29 18 25  1.14 0.68 C 
96 77 91 72 27  0.68 0.43 C 
66 39 41 14 30  0 0 B 
70 52 37 19 22  0 0 B 
32 17 37 22 17  0.52 0.39 A 
182 163 36 17 3  1.02 0.56 A 
32 27 22 17 14 52 0.35 0.31 A 
60 45 28 14 20 60 0 0 B 
73 45 44 16 31 73 4.692 0.454 C 
27 30 19 12 10 57 0 0 B 
77 61 27 11 19 77 0.617 0.383 C 
40 14 32 6 30 60 0.762 0.664 C 
54 33 31 10 24 54 4.82 4.25 A 
217 204 27 14 17 52 0.6 1.46 C 
         
101 73 51 23 36 51 0 0 B 
125 110 31 16 21 37 0 0 A 
215 190 65 40 26 70 0.92 0.74 C 
75 64 33 22 21 73 0.25 0.27 B 
193 145 68 20 50 87 0.86 0.68 A 
58 50 18 11 10 52 0.941 0.857 A 
119 101 46 29 22 86 0.517 0.722 C 
223 200 43 20 28 99 0.88 0.66 A 
100 88 30 18 15 65 0.27 0.26 B 
50 33 32 15 20 60 0.63 0.58 C 
187 168 40 19 23 58 0 0 B 
68 60 28 20 14 68 0.73 0.8 C 
98 86 35 23 16 98 0.87 0.71 A 
54 47 24 17 11 42 0 0 B 
79 67 39 27 17 80 2.2 1.8 C 
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name hosp.no age weight gender duration 
serial 
no T.F.E grade 
no: 
cough      sed 0 sed10 
radha 238485d 38 77 f 130 41 18 1 1 1
sujith 240963d 52 46 m 260 42 15 2 7 2
anuj 164590d 20 55 m 135 43 19 1 3 1
md.jahangir 231797d 26 72 m 315 44 20 2 7 2
jeyanti 060024b 38 61 f 200 45 15 1 1 2
abha 242263d 28 68 f 165 46 11 2 8 2
rajendra 237869d 38 55 m 247 47 21 2 4 1
dilip 191757d 29 65 m 160 48 15 2 10 1
lakhi 231409d 48 61 f 175 49 21 2 6 3
amarender 247949d 43 52 m 210 50 18 2 10 2
bindu 240557d 22 55 f 210 51 19 2 6 1
karthik 249249d 52 57 m 190 52 24 1 2 1
narendra 237600d 66 58 m 190 53 13 1 1 2
sekhar 243382d 30 85 m 225 54 9 1 3 2
anup 250688d 31 67 m 150 55 11 1 2 2
mathew 252296d 49 65 m 240 56 16 1 0 0
rudha 253409d 36 50 f 240 57 20 1 0 1
tushar 248861d 24 51 m 270 58 18 2 5 2
noyan 257697d 35 52 f 240 59 14 1 0 0
alo mazum 252123d 60 46 f 195 60 21 1 6 0
syed amn 230225d 34 100 m 210 61 12 2 2 3
fatema 231647d 53 65 f 220 62 22 1 3 2
swarup 254245d 37 72 m 202 63 9 1 2 3
saritha 219743d 22 70 f 205 64 21 1 0 2
kamala 258825d 38 50 f 255 65 27 1 0 2
brijendra 240257d 50 60 m 180 66 15 1 2 1
sheik sal 246767d 26 78 m  67 16 2 22 0
sonam 169753d 26 48 f 300 68 14 1 0 2
sah newas 248990d 18 63 m 405 69 38 2 5 3
            
manju 258936d 40 82 f 110 71 15 2 10 3
rejeya 259846d 51 50 f 320 72 25 1 3 3
kamalika 266602d 22 58 f 260 73 41 1 0 3
syeda 270432d 22 57 f 420 74 25 2 10 2
hridoy 250178d 21 50 m 145 75 24 1 1 3
nasrin 272016d 34 73 f 195 76 13 2 8 3
sisir 270398d 29 60 m 240 77 34 1 0 3
andrews 264919d 50 66 m 150 78 16 1 1 2
rahul 251005d 20 60 m 325 79 24 1 2 3
hazi md 271282d 61 60 m 155 80 17 2 10 3
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sed10 B. SBP B.DBP B.MBP B.HR
SD. 
SBP SD.DBP SD.MBP SD.HR Pre.SBP Pre.DBP Pre.MBP
0 120 80 93 79 85 62 69 73 103 75 85
2 140 90 107 100 92 55 71 81 96 53 71
0 130 80 97 96 96 46 63 109 98 49 66
2 130 80 97 63 98 59 72 70 114 70 85
1 110 80 90 80 115 68 80 104 105 71 78
1 110 70 83 80 82 54 62 85 111 60 73
0 110 80 90 80 85 58 64 74 104 60 78
0 130 80 97 86 113 67 81 87 102 57 72
2 122 90 101 86 102 79 90 92 128 75 96
1 120 86 97 70 91 55 67 64 112 74 92
1 124 76 92 70 92 52 63 95 118 63 79
0 150 80 103 76 100 53 71 80 113 59 79
1 140 80 100 80 96 47 65 64 118 45 73
1 130 90 103 88 99 67 78 82 128 83 97
1 130 80 97 84 97 55 69 104 98 60 73
0 130 90 103 78 94 45 59 84 103 48 63
0 128 94 105 74 72 45 54 80 94 55 70
2 110 80 90 80 96 56 69 120 112 52 72
0 120 70 87 118 109 57 75 91 128 70 91
0 150 90 110 78 121 50 73 90 174 75 107
2 120 80 93 70 100 64 77 82 99 71 83
2 120 80 93 68 74 35 49 75 78 37 52
2 110 70 83 86 130 64 81 62 130 59 80
2 120 80 93 82 97 60 73 86 103 64 78
2 130 90 103 82 107 48 66 63 112 55 74
1 160 100 120 90 84 66 73 93 122 75 94
0 130 80 97 80 120 67 86 69 119 64 82
2 110 70 83 68 120 57 80 87 125 61 86
2 100 70 80 100 102 70 81 122 110 72 85
   0         
3 150 90 110 100 100 44 61 101 108 49 66
3 130 90 103 72 110 76 92 75 100 70 84
2 104 70 81 90 110 68 85 89 112 66 87
1 100 80 87 88 90 60 69 106 100 50  
3 110 70 83 68 96 53 67 77 104 51 66
2 120 80 93 84 100 63 78 72 106 67 83
3 100 70 80 84 96 51 64 110 103 55 69
1 120 70 87 80 97 52 68 92 104 55 71
3 100 70 80 76 96 58 69 110 110 64 76
1 130 80 97 80 84 62 67 66 93 61 66
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P1MBP P1HR P2SBP P2DBP P2MBP P2HR P3SBP P3DBP P3MBP P3HR P4SBP P4DBP
132 82 181 136 140 87 157 107 128 87 164 110
65 86 120 80 88 87 112 58 81 87 121 61
90 128 119 61 82 116 148 68 92 129 128 66
95 83 132 70 94 70 125 74 94 72 125 78
85 94 122 79 89 92 120 58 61 92 108 62
74 85 113 58 72 82 117 61 76 82 112 57
97 104 120 67 90 94 114 62 84 101 119 67
122 106 130 84 109 111 155 85 113 114 144 87
96 100 131 81 103 100 130 78 100 101 114 65
92 69 127 78 100 61 128 79 101 73 136 71
94 89 124 75 96 88 136 78 101 90 137 91
109 79 144 89 109 80 154 70 102 76 144 74
73 73 104 41 63 73 115 44 68 73 109 43
93 97 120 54 82 96 125 85 99 94 128 87
77 120 105 65 81 119 97 60 72 109 82 51
82 104 114 64 82 106 128 73 91 105 128 73
116 94 149 88 115 94 144 85 112 96 142 81
69 116 109 53 73 90 114 49 73 86 106 57
99 106 140 88 111 102 135 86 107 88 134 87
105 128 178 90 125 125 188 85 127 106 171 83
104 78 117 91 106 79 145 84 110 79 147 86
57 94 87 43 58 95 87 43 58 95 86 43
82 60 116 52 79 65 127 64 86 62 126 64
115 97 140 86 109 95 127 67 94 92 137 80
83 60 113 57 81 56 115 56 80 52 113 54
110 98 141 91 109 97 142 92 110 96 132 95
104 84 153 84 110 75 149 83 105 73 149 85
89 111 115 56 76 100 120 53 76 90 121 47
91 120 130 73 91 84 128 73 89 90 124 74
            
 120 128 67 85 129 129 66 86 129 128 64
93 89 147 72 99 88 161 73 100 90 147 72
87 81 135 70 91 76 132 67 92 76 132 67
 111 123 62 80 113 122 62 80 118 123 62
 98 120 66 83 98 120 60 80 94 128 68
97 78 118 71 92 77 122 72 94 77 120 74
88 110 120 70 85 108 121 70 85 108 121 70
102 93 133 95 109 92 139 68 93 95 141 68
87 114 124 63 83 88 129 59 84 82 130 62
105 88 136 88 99 84 138 85 97 80 129 81
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P5SBP P5DBP P5MBP P5HR Fe-Ex Fe-Rev Vec-Ex 
Vec-
Rev Sd-Ex Iso-Ex Plasma1 plasma2
 
109 130 87 75 58 30 13 19 45 0.64 0.49 A 
61 65 87 88 75 53 40 20 72 0 0 B 
66 87 119 72 54 39 21 26 73 0 0 B 
72 92 72 72 52 31 11 23 71 0.72 0.87 C 
69 72 93 89 75 35 21 19 79 2.59 insufficient A 
58 72 82 92 83 28 19 17 91 1.4 1.22 C 
64 87 94 71 52 56 37 24 56 0 0 B 
87 108 118 57 42 45 31 20 55 1 0.6 A 
63 82 102 123 104 27 8 23 88 0 0 B 
78 101 77 75 62 28 19 22 76 0.84 0.79 A 
80 99 105 62 46 35 19 25 58 0 0 B 
74 101 74 60 42 30 12 26 57 0.59 0.41 C 
46 71 73 82 69 32 19 21 82 0.54 0.26 A 
83 97 90 179 172 24 17 14 60 0 0 C 
58 71 95 60 52 17 15 12 60 0 0 B 
76 95 103 70 56 25 9 18 65 0 0 A 
79 105 96 65 53 50 38 20 60 0.24 0.27 A 
55 77 103 183 167 43 27 20 58 0.48 0.39 C 
86 108 81 85 75 50 40 16 80 0 0 B 
83 122 95 109 92 39 22 21 99 0.79 0.7 C 
87 110 75 91 80 54 45 16 58 1.94 2.4 C 
42 58 95 36 17 36 17 22 66 0 0 B 
72 90 61 30 25 20 15 14 40 0.75 0.55 A 
84 105 109 71 52 51 32 24 71 0 0 B 
52 77 50 68 42 38 12 28 63 0.88 0.57 C 
98 112 94 121 107 31 17 19 51 0 0 B 
80 107 72 68 53 28 13 23 71 0.7 0.52 A 
44 67 77 75 61 30 16 17 70 0.78 1.1 C 
71 86 106 200 163 57 20 47 200 1.33 1 A 
        0.89 0.76 C 
67 87 126 58 46 31 19 17 58 0 0 B 
67 95 79 70 46 45 21 27 60 1.07 0.71 A 
64 92 73 97 57 51 11 45 92 1.56 0.35 C 
63 81 115 89 74 43 29 30 85 0 0 B 
65 85 87 68 53 46 31 19 65 0.56 0.31 A 
77 97 80 56 46 25 15 18 66 1.05 0.29 A 
65 81 107 91 59 49 17 37 89 0 0 B 
68 92 93 185 174 25 14 16 57 0.57 0.53 C 
61 83 93 66 43 41 18 27 72 0.88 0.61 C 
78 89 79 163 149 31 17 20 52 0 0 B 
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selvam 268565d 46 65 m 220 81 7 2 8 3
kamrul 273547d 45 60 m 185 82 13 2 2 3
priyanka 258296d 28 47 f 120 83 18 2 8 2
mofik 267248d 34 60 m 180 84 13 1 3 2
tetru 260852d 41 70 m 330 85 18 1 3 0
piu 269953d 23 50 f 190 86 14 1 3 0
gumni 274252d 52 38 f 90 87 24 1 0 3
dipali 269410d 51 55 f 140 88 15 2 4 2
subas 268936d 50 71 m 180 89 9 1 3 1
rinku 273852d 26 50 f 125 90 15 1 1 2
sitala 274793d 52 45 f 315 91 25 1 0 3
Kumar 272920d 53 77 m 130 92 12 2 7 1
sabithra 271167d 33 55 f 270 93 10 1 1 2
biswajit 277045d 22 47 m 135 94 12 2 4 3
mina 
saha 279713d 57 67 f 135 95 12 1 0 1
kurien 270109d 30 61 m 270 96 12 1 1 3
poonam 274894d 24 51 f 210 97 7 1 4 3
debtosh 256683d 37 60 m 255 98 15 2 5 3
avijit 025095d 29 71 m 120 99 25 2 10 1
md abdul 274128d 43 65 m 180 100 8 3 10 1
haru gorai 277748d 42 47 m 420 101 14 1 0 3
kaushal 205737d 24 40 m 210 102 17 1 4 2
poonam 274894d 24 52 f 275 103 20 1 1 2
bijoli 282211d 44 55 f 300 104 9 2 6 1
rehana 276773d 53 76 f 240 105 20 2 6 3
binita 281912d 22 36 f 220 106 21 1 1 0
hussain 274343d 50 72 m 285 107 26 1 2 3
jayanta 276458d 47 52 m 310 108 20 2 9 3
harikishan 287284d 21 60 m 225 109 3 2 9 0
madhuri 282778d 38 70 f 300 110 9 1 1 3
tapan 293066d 22 46 m 185 111 19 2 8 1
palani 299209d 60 58 m 200 112 9 2 10 3
manoranj 276932d 34 45 m 105 113 22 1 2 2
samir 196995d 45 70 m 270 114 20 1 1 2
sanjay 300919d 38 65 m 295 115 15 2 3 1
abdul 276991d 38 67 m 185 116 12 2 3 3
 
name hosp.no age weight gender duration 
serial 
no T.F.E grade 
no: 
cough      sed 0 sed10 
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 B.DBP B.MBP B.HR 
SD. 
SBP SD.DBP SD.MBP SD.HR Pre.SBP Pre.DBP Pre.MBP Pre.HR
110 70 83 86 143 76 101 72 134 70 92 76
120 90 100 100 76 49 60 89 102 62 79 94
110 70 83 84 97 61 74 103 101 66 78 105
130 70 90 72 89 46 64 85 97 49 70 83
130 70 90 88 101 61 75 93 116 74 90 109
120 80 93 88 75 49 58 97 82 52 62 98
140 80 100 88 117 60 81 87 120 84 88 87
130 80 97 88 100 47 63 108 130 59 79 112
130 90 103 82 82 46 57 49 94 52 68 53
110 70 83 80 74 53 60 107 86 56 68 101
118 76 90 98 79 48 60 97 118 68 89 102
120 80 93 64 110 64 82 58 114 67 86 57
130 84 99 78 127 63 86 95 130 71 92 90
120 86 97 102 108 54 74 87 107 68 83 90
110 80 90 80 126 63 82 70 130 66 84 85
130 90 103 88 91 58 71 80 100 65 79 80
108 70 83 86 92 46 59 119 94 45 59 107
119 64 82 100 118 65 82 100 123 63 84 104
110 80 90 68 100 58 72 105 99 55 70 105
118 76 90 76 130 64 80 110 132 62 80 113
110 70 83 82 109 67 81 107 104 65 78 108
110 80 90 88 87 42 57 86 86 40 56 87
100 60 73 86 116 68 83 86 130 78 96 89
130 70 90 80 121 63 84 60 115 77 94 68
156 94 115 92 99 59 76 73 114 61 83 91
100 70 80 80 80 51 64 110 94 56 72 106
140 94 109 86 78 45 56 71 83 48 60 71
120 70 87 84 81 43 57 120 116 63 82 125
110 80 90 80 105 67 81 100 116 68 84 94
100 70 80 92 99 63 79 100 113 73 90 103
110 70 83 68 108 68 83 95 130 80 100 82
140 80 100 85 122 62 81 97 102 54 68 86
100 70 80 90 82 43 54 95 76 40 51 94
130 80 97 72 90 38 51 90 94 38 53 93
120 84 96 86 100 51 66 85 105 50 67 78
110 76 83 80 90 66 54 90 86 65 49 88
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P1MB
P 
P1HR P2SBP P2DBP P2MB
P 
P2HR P3SBP P3DBP P3MB
P 
P3HR P4SBP P4DBP P4MB
P 
P4HR 
118 117 155 79 105 99 142 70 96 86 145 70
99 102 127 76 98 102 131 78 100 103 134 88
84 108 103 69 84 111 103 68 83 110 103 67
75 108 110 75 85 105 116 85 88 100 102 62
95 109 123 72 92 103 122 74 93 100 121 70
83 130 122 61 80 122 118 61 80 123 126 62
118 93 158 80 117 90 170 84 122 89 167 78
112 115 148 70 99 112 150 71 98 114 144 69
97 60 142 70 100 61 142 74 102 61 148 79
77 116 88 58 70 115 94 58 70 122 96 56
113 116 154 85 115 115 159 79 114 111 150 78
114 68 180 94 124 71 179 89 119 66 188 93
109 110 123 73 94 111 129 75 95 111 127 73
89 87 113 74 84 87 119 70 88 87 120 70
115 90 152 82 104 86 150 80 100 87 156 81
88 88 108 69 86 89 122 77 96 88 122 80
70 114 103 48 65 111 104 47 64 109 104 45
86 98 127 61 86 98 127 60 82 99 127 61
98 111 143 83 100 107 144 82 100 107 151 85
105 123 162 86 111 130 151 81 102 126 155 83
108 110 145 79 106 113 146 86 108 104 137 83
81 114 110 50 68 109 118 52 74 109 110 56
90 80 120 72 94 82 126 69 92 79 130 72
97 55 129 72 95 55 126 70 93 54 124 71
97 99 126 70 95 92 134 71 99 85 139 70
71 126 90 63 74 129 96 67 76 128 99 68
79 86 116 62 84 78 112 62 83 74 118 69
87 126 118 70 92 124 119 69 90 123 122 68
79 84 112 70 79 84 111 68 78 82 114 69
101 108 117 74 90 105 112 69 87 100 119 72
106 98 132 86 107 97 140 85 109 95 161 86
103 84 165 71 104 86 158 68 99 87 163 70
85 85 117 64 85 84 127 67 89 80 125 66
89 102 147 73 98 99 151 73 98 90 151 71
93 88 134 74 95 90 131 70 91 92 118 67
53 92 128 90 68 87 126 66 87 87 126 66
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P5SBP P5DBP P5MB
P 
P5HR Fe-Ex Fe-Rev Vec-Ex Vec-
Rev 
Sd-Ex Iso-Ex Plasm
a1 
plasma
2 
code 
149 72 99 85 72 66 37 31 14 63 0.704 1.23
134 80 104 107 79 67 29 17 16 79 0 0
104 67 84 106 76 59 27 10 21 77 0 0
105 59 80 95 52 43 24 15 15 47 0.48 0.47
120 70 90 100 153 126 33 31 23 103 0 0
120 62 81 127 86 73 35 20 19 85 0.8 0.82
171 73 111 76 52 30 37 15 29 72 0.64 0.44
138 65 92 115 163 154 52 41 18 68 0 0
150 79 108 64 65 56 30 21 17 60 0.85 0.66
95 57 71 122 41 29 21 9 19 41 0 0
147 76 106 109 113 89 33 9 27 83 0.66 0
185 92 122 63 71 59 21 9 15 76 0.67 0.57
122 72 91 112 75 66 45 36 15 45 0 0
122 74 96 88 47 36 22 11 13 47 0.33 0.59
155 78 101 119 53 41 23 11 17 53 1.209 1.043
118 78 95 89 92 80 27 15 17 92 0 0
105 46 64 110 39 32 24 17 10 49 0.76 0.75
131 61 83 100 56 41 31 16 18 56 0 0
130 72 90 106 71 46 38 13 28 70 0.47 0.34
149 79 102 125 55 48 19 12 13 59 0 0
137 87 105 111 69 56 24 11 15 69 0.73 0.56
118 54 77 112 72 55 30 13 20 72 0 0
132 75 98 78 64 48 56 40 28 64 0 0
123 69 91 54 53 49 23 19 10 53 1.16 1.1
141 71 101 82 70 51 40 21 23 60 1.06 0.76
97 62 74 128 85 55 42 22 21 80 0.38 1.1
115 62 84 73 57 38 31 12 26 55 0.77 0.38
127 65 89 120 66 49 26 9 21 60 0.13 0.14
120 69 80 84 46 44 37 35 7 61 interferenc 2.74
121 74 92 101 84 79 19 14 11 84 0.82 1.39
151 89 115 94 38 22 30 14 22 62 0 0
162 68 99 89 51 43 20 12 9 51 0.67 0.59
125 125 64 87 53 30 36 13 26 53 0.57 0.45
145 67 91 88 125 106 34 15 25 60 0.86 0.63
127 68 91 87 42 28 32 18 19 62 2.13 0.28
126 68 90 87 71 61 17 7 14 68 0 0
 
name hosp.no age weight gender duration serial no T.F.E grade
mohan 192487d 39 86 m 175 2 30 2
shivmani 189060d 63 63 f 330 3 26 1
pavan kum 196698d 25 51 m 135 4 17 2
mohd.nes 197050d 19 55 m 310 5 18 2
sukla lehri 189448d 43 60 f 270 6 11 1
basudev 178491d 43 60 m 180 7 17 1
sadere ala 198598d 48 72 m 191 8 17 2
rahamath 191504d 20 40 f 240 9 22 3
subramani 166435d 56 66 m 250 10 9 1
mazumdar 193332d 38 59 m 300 11 13 1
soumitra 193623d 29 46 m 180 12 26 1
sadhana r 201551d 35 48 f 120 13 27 1
dropadi de 197921d 43 43 f 230 14 21 1
vengaiama 639425c 27 48 f 320 15 17 1
tarapada 187186d 43 80 m 185 16 20 2
sitara bibi 200693b 35 49 f 300 17 7 1
aparna das204773d 31 47 f 180 18 15 1
samit k 199805d 42 60 m 330 19 27 3
 soma.m 208075d 35 60 f 232 20 7 2
ashok 992038c 39 88 m 180 21 17 1
sankar 204723d 62 60 m 283 22 30 1
sultan 213989d 52 63 m 220 23 22 2
arumugam 158764d 64 51 m 203 24 14 1
amir ali 162975d 37 58 m 270 26 31 1
nabanita 217753d 18 84 f 335 27 16 1
snigdha 188213 36 69 f 290 28 25 3
yusuf 159898d 44 75 m 195 29 17 1
surjeet 213561d 37 85 m 215 30 48 1
pritwish 221015d 18 49 m 156 31 8 2
jayantha 223475d 20 63 m 440 32 21 1
mohd ali 227326d 48 72 m 218 33 27 2
mustafa 224955d 43 65 m 90 34 12 1
ananta das 219327d 24 66 m 180 35 17 2
anju sil 217009d 53 64 f 300 36 21 3
manik lal 233592d 56 76 m 90 37 11 1
roy george 236628d 41 82 m 240 38 14 2
amit 206886d 32 82 m 75 39 7 2
kousalya 221688d 28 52 f 205 40 14 1
radha 238485d 38 77 f 130 41 18 1
sujith 240963d 52 46 m 260 42 15 2
anuj 164590d 20 55 m 135 43 19 1
md.jahangi 231797d 26 72 m 315 44 20 2
jeyanti 060024b 38 61 f 200 45 15 1
abha 242263d 28 68 f 165 46 11 2
rajendra 237869d 38 55 m 247 47 21 2
dilip 191757d 29 65 m 160 48 15 2
lakhi 231409d 48 61 f 175 49 21 2
amarender 247949d 43 52 m 210 50 18 2
bindu 240557d 22 55 f 210 51 19 2
karthik 249249d 52 57 m 190 52 24 1
narendra 237600d 66 58 m 190 53 13 1
sekhar 243382d 30 85 m 225 54 9 1
anup 250688d 31 67 m 150 55 11 1
mathew 252296d 49 65 m 240 56 16 1
rudha 253409d 36 50 f 240 57 20 1
tushar 248861d 24 51 m 270 58 18 2
noyan 257697d 35 52 f 240 59 14 1
alo mazum 252123d 60 46 f 195 60 21 1
syed amn 230225d 34 100 m 210 61 12 2
fatema 231647d 53 65 f 220 62 22 1
swarup 254245d 37 72 m 202 63 9 1
saritha 219743d 22 70 f 205 64 21 1
kamala 258825d 38 50 f 255 65 27 1
brijendra 240257d 50 60 m 180 66 15 1
sheik sal 246767d 26 78 m 67 16 2
sonam 169753d 26 48 f 300 68 14 1
sah newas 248990d 18 63 m 405 69 38 2
manju 258936d 40 82 f 110 71 15 2
rejeya 259846d 51 50 f 320 72 25 1
kamalika 266602d 22 58 f 260 73 41 1
syeda 270432d 22 57 f 420 74 25 2
hridoy 250178d 21 50 m 145 75 24 1
nasrin 272016d 34 73 f 195 76 13 2
sisir 270398d 29 60 m 240 77 34 1
andrews 264919d 50 66 m 150 78 16 1
rahul 251005d 20 60 m 325 79 24 1
hazi md 271282d 61 60 m 155 80 17 2
selvam 268565d 46 65 m 220 81 7 2
kamrul 273547d 45 60 m 185 82 13 2
priyanka 258296d 28 47 f 120 83 18 2
mofik 267248d 34 60 m 180 84 13 1
tetru 260852d 41 70 m 330 85 18 1
piu 269953d 23 50 f 190 86 14 1
gumni 274252d 52 38 f 90 87 24 1
dipali 269410d 51 55 f 140 88 15 2
subas 268936d 50 71 m 180 89 9 1
rinku 273852d 26 50 f 125 90 15 1
sitala 274793d 52 45 f 315 91 25 1
Kumar 272920d 53 77 m 130 92 12 2
sabithra 271167d 33 55 f 270 93 10 1
biswajit 277045d 22 47 m 135 94 12 2
mina saha 279713d 57 67 f 135 95 12 1
kurien 270109d 30 61 m 270 96 12 1
poonam 274894d 24 51 f 210 97 7 1
debtosh 256683d 37 60 m 255 98 15 2
avijit 025095d 29 71 m 120 99 25 2
md abdul 274128d 43 65 m 180 100 8 3
haru gorai 277748d 42 47 m 420 101 14 1
kaushal 205737d 24 40 m 210 102 17 1
poonam 274894d 24 52 f 275 103 20 1
bijoli 282211d 44 55 f 300 104 9 2
rehana 276773d 53 76 f 240 105 20 2
binita 281912d 22 36 f 220 106 21 1
hussain 274343d 50 72 m 285 107 26 1
jayanta 276458d 47 52 m 310 108 20 2
harikishan 287284d 21 60 m 225 109 3 2
madhuri 282778d 38 70 f 300 110 9 1
tapan 293066d 22 46 m 185 111 19 2
palani 299209d 60 58 m 200 112 9 2
manoranj 276932d 34 45 m 105 113 22 1
samir 196995d 45 70 m 270 114 20 1
sanjay 300919d 38 65 m 295 115 15 2
abdul 276991d 38 67 m 185 116 12 2
no: cough  sed 0 sed10 B. SBP B.DBP B.MBP B.HR SD. SBP SD.DBP
5 2 1 110 80 90 80 114 78
3 2 1 140 90 107 80 98 53
10 1 0 106 60 75 90 105 55
5 2 1 130 80 97 80 120 72
3 2 1 120 70 87 88 122 73
2 2 2 130 90 103 78 101 64
8 2 2 130 80 97 82 93 63
10 1 0 110 80 90 80 130 93
4 2 1 140 100 113 84 92 57
1 2 1 140 90 107 92 94 53
2 2 1 134 80 98 120 106 61
0 0 0 108 77 87 79 107 75
3 2 2 110 70 83 100 93 54
0 0 0 100 68 79 98 79 46
6 2 2 130 90 103 80 109 68
2 2 1 126 86 99 83 102 50
0 2 1 110 76 87 83 109 60
10 2 1 104 68 80 78 103 58
6 2 2 120 80 93 86 112 50
5 2 1 140 90 107 72 108 62
0 2 1 110 76 87 78 102 55
7 1 1 110 92 98 96 114 71
3 2 1 150 80 103 64 139 77
0
1 2 1 114 68 83 70 89 42
2 2 2 120 90 100 90 124 78
10 0 0 140 90 107 88 121 76
3 2 1 140 90 107 84 100 60
4 2 2 140 90 107 94 108 73
7 3 2 130 90 103 102 103 57
2 1 1 100 70 80 82 114 67
6 2 1 140 80 100 101 120 81
1 0 0 140 80 100 90 120 75
8 2 1 120 80 93 72 108 66
9 2 2 130 90 103 88 91 40
1 1 0 120 90 100 92 115 57
7 2 1 120 90 100 84 122 75
10 1 0 110 60 77 80 117 66
1 0 0 140 80 100 88 92 60
1 1 0 120 80 93 79 85 62
7 2 2 140 90 107 100 92 55
3 1 0 130 80 97 96 96 46
7 2 2 130 80 97 63 98 59
1 2 1 110 80 90 80 115 68
8 2 1 110 70 83 80 82 54
4 1 0 110 80 90 80 85 58
10 1 0 130 80 97 86 113 67
6 3 2 122 90 101 86 102 79
10 2 1 120 86 97 70 91 55
6 1 1 124 76 92 70 92 52
2 1 0 150 80 103 76 100 53
1 2 1 140 80 100 80 96 47
3 2 1 130 90 103 88 99 67
2 2 1 130 80 97 84 97 55
0 0 0 130 90 103 78 94 45
0 1 0 128 94 105 74 72 45
5 2 2 110 80 90 80 96 56
0 0 0 120 70 87 118 109 57
6 0 0 150 90 110 78 121 50
2 3 2 120 80 93 70 100 64
3 2 2 120 80 93 68 74 35
2 3 2 110 70 83 86 130 64
0 2 2 120 80 93 82 97 60
0 2 2 130 90 103 82 107 48
2 1 1 160 100 120 90 84 66
22 0 0 130 80 97 80 120 67
0 2 2 110 70 83 68 120 57
5 3 2 100 70 80 100 102 70
0
10 3 3 150 90 110 100 100 44
3 3 3 130 90 103 72 110 76
0 3 2 104 70 81 90 110 68
10 2 1 100 80 87 88 90 60
1 3 3 110 70 83 68 96 53
8 3 2 120 80 93 84 100 63
0 3 3 100 70 80 84 96 51
1 2 1 120 70 87 80 97 52
2 3 3 100 70 80 76 96 58
10 3 1 130 80 97 80 84 62
8 3 2 110 70 83 86 143 76
2 3 2 120 90 100 100 76 49
8 2 1 110 70 83 84 97 61
3 2 2 130 70 90 72 89 46
3 0 0 130 70 90 88 101 61
3 0 0 120 80 93 88 75 49
0 3 3 140 80 100 88 117 60
4 2 2 130 80 97 88 100 47
3 1 1 130 90 103 82 82 46
1 2 2 110 70 83 80 74 53
0 3 3 118 76 90 98 79 48
7 1 0 120 80 93 64 110 64
1 2 1 130 84 99 78 127 63
4 3 1 120 86 97 102 108 54
0 1 0 110 80 90 80 126 63
1 3 1 130 90 103 88 91 58
4 3 1 108 70 83 86 92 46
5 3 2 119 64 82 100 118 65
10 1 1 110 80 90 68 100 58
10 1 1 118 76 90 76 130 64
0 3 2 110 70 83 82 109 67
4 2 1 110 80 90 88 87 42
1 2 2 100 60 73 86 116 68
6 1 0 130 70 90 80 121 63
6 3 1 156 94 115 92 99 59
1 0 0 100 70 80 80 80 51
2 3 3 140 94 109 86 78 45
9 3 3 120 70 87 84 81 43
9 0 0 110 80 90 80 105 67
1 3 2 100 70 80 92 99 63
8 1 0 110 70 83 68 108 68
10 3 2 140 80 100 85 122 62
2 2 1 100 70 80 90 82 43
1 2 0 130 80 97 72 90 38
3 1 0 120 84 96 86 100 51
3 3 2 110 76 83 80 90 66
SD.MBP SD.HR Pre.SBP Pre.DBP Pre.MBP Pre.HR P1SBP P1DBP P1MBP
90 103 108 71 83 102 131 83 101
66 106 106 61 78 110 122 84 65
71 110 111 60 75 112 120 68 85
88 106 120 71 89 100 137 84 106
92 101 123 70 91 103 125 72 92
78 83 108 62 79 90 147 83 106
75 82 104 69 83 90 156 88 118
106 106 122 84 105 87 137 92 109
70 109 109 63 78 118 124 69 91
67 122 99 53 69 128 131 88 103
71 101 104 51 70 80 116 59 83
90 80 122 87 102 81 166 98 127
70 93 101 57 75 86 122 70 94
60 116 89 54 69 121 120 69 86
84 80 92 55 69 72 115 64 82
69 100 110 51 71 110 112 58 77
76 91 122 64 85 97 115 65 86
71 105 95 52 67 102 158 75 103
74 111 116 50 72 108 154 66 99
78 95 105 60 76 85 127 70 91
70 80 154 74 101 81 178 93 127
89 74 125 78 98 73 144 77 101
104 77 130 68 94 81 132 71 100
55 84 137 58 82 85 141 70 93
94 106 131 71 88 103 164 92 113
94 97 113 63 81 89 135 88 101
74 82 123 64 89 81 122 67 87
87 88 109 76 90 86 132 82 102
73 133 132 73 93 139 140 76 99
83 119 138 87 102 128 134 81 97
98 95 120 77 95 94 147 91 110
95 78 123 74 94 77 145 90 83
97 89 115 67 82 80 143 81 99
57 80 120 53 74 111 152 72 98
77 77 133 62 86 78 200 90 128
90 103 126 85 108 94 123 80 95
83 109 119 66 86 114 137 80 98
73 106 109 66 87 85 115 70 90
69 73 103 75 85 76 165 112 132
71 81 96 53 71 82 94 45 65
63 109 98 49 66 107 141 69 90
72 70 114 70 85 75 127 80 95
80 104 105 71 78 106 124 75 85
62 85 111 60 73 87 101 62 74
64 74 104 60 78 73 125 78 97
81 87 102 57 72 82 156 97 122
90 92 128 75 96 94 128 73 96
67 64 112 74 92 63 104 77 92
63 95 118 63 79 86 119 70 94
71 80 113 59 79 76 149 80 109
65 64 118 45 73 71 123 46 73
78 82 128 83 97 90 128 82 93
69 104 98 60 73 105 104 62 77
59 84 103 48 63 89 119 62 82
54 80 94 55 70 80 150 91 116
69 120 112 52 72 97 91 59 69
75 91 128 70 91 76 131 76 99
73 90 174 75 107 125 143 85 105
77 82 99 71 83 78 135 85 104
49 75 78 37 52 78 83 40 57
81 62 130 59 80 58 128 62 82
73 86 103 64 78 81 154 96 115
66 63 112 55 74 74 114 60 83
73 93 122 75 94 90 136 89 110
86 69 119 64 82 67 144 80 104
80 87 125 61 86 91 136 66 89
81 122 110 72 85 106 134 75 91
61 101 108 49 66 105 130 70
92 75 100 70 84 68 148 64 93
85 89 112 66 87 96 129 65 87
69 106 100 50 110 106 56
67 77 104 51 66 63 136 75
78 72 106 67 83 62 127 76 97
64 110 103 55 69 103 126 72 88
68 92 104 55 71 92 158 72 102
69 110 110 64 76 102 121 72 87
67 66 93 61 66 68 144 93 105
101 72 134 70 92 76 166 89 118
60 89 102 62 79 94 128 75 99
74 103 101 66 78 105 107 67 84
64 85 97 49 70 83 107 57 75
75 93 116 74 90 109 124 77 95
58 97 82 52 62 98 123 64 83
81 87 120 84 88 87 164 82 118
63 108 130 59 79 112 166 85 112
57 49 94 52 68 53 132 69 97
60 107 86 56 68 101 101 64 77
60 97 118 68 89 102 152 84 113
82 58 114 67 86 57 167 85 114
86 95 130 71 92 90 144 90 109
74 87 107 68 83 90 127 84 89
82 70 130 66 84 85 167 89 115
71 80 100 65 79 80 111 71 88
59 119 94 45 59 107 108 53 70
82 100 123 63 84 104 128 66 86
72 105 99 55 70 105 145 76 98
80 110 132 62 80 113 153 82 105
81 107 104 65 78 108 144 89 108
57 86 86 40 56 87 116 60 81
83 86 130 78 96 89 116 69 90
84 60 115 77 94 68 130 73 97
76 73 114 61 83 91 128 72 97
64 110 94 56 72 106 96 60 71
56 71 83 48 60 71 109 59 79
57 120 116 63 82 125 108 70 87
81 100 116 68 84 94 112 70 79
79 100 113 73 90 103 132 84 101
83 95 130 80 100 82 134 83 106
81 97 102 54 68 86 158 72 103
54 95 76 40 51 94 117 64 85
51 90 94 38 53 93 141 67 89
66 85 105 50 67 78 130 76 93
54 90 86 65 49 88 101 69 53
8961
P1HR P2SBP P2DBP P2MBP P2HR P3SBP P3DBP P3MBP P3HR
102 127 82 98 103 130 82 100 102
110 109 56 68 112 114 68 87 118
133 115 63 80 126 116 62 79 126
89 136 79 102 91 126 72 93 104
102 128 77 97 102 145 92 124 106
102 158 87 111 102 151 81 106 102
87 164 91 122 88 168 92 124 85
103 160 98 119 87 139 97 105 100
126 138 81 101 124 136 80 99 123
128 127 82 98 129 123 80 98 123
108 119 63 86 112 117 61 84 112
89 164 97 124 90 160 96 123 86
94 102 65 82 99 114 70 89 83
119 112 70 107 119 103 68 82 119
90 138 83 106 139 139 84 103 145
112 112 59 78 110 113 59 79 110
104 118 63 85 93 122 61 84 89
106 147 71 97 104 146 73 97 100
112 136 58 87 114 139 59 89 114
90 124 70 90 90 135 82 101 89
92 177 92 124 87 175 90 124 90
79 154 78 104 79 160 77 106 85
82 145 74 106 80 149 75 108 80
80 126 58 80 89 128 58 81 85
121 147 83 107 114 156 86 111 112
107 125 75 98 98 122 70 90 101
75 106 61 77 69 111 59 76 69
89 127 73 94 88 139 81 102 87
137 135 78 101 145 140 80 102 139
130 133 81 97 120 143 84 104 118
91 153 100 118 91 154 99 124 89
75 165 93 126 90 147 87 104 90
94 122 70 88 99 130 69 88 78
112 118 65 84 111 125 65 86 111
90 171 81 116 90 150 77 107 87
99 129 86 105 90 138 86 107 91
121 135 75 95 115 126 73 93 112
102 123 75 95 102 121 72 90 99
82 181 136 140 87 157 107 128 87
86 120 80 88 87 112 58 81 87
128 119 61 82 116 148 68 92 129
83 132 70 94 70 125 74 94 72
94 122 79 89 92 120 58 61 92
85 113 58 72 82 117 61 76 82
104 120 67 90 94 114 62 84 101
106 130 84 109 111 155 85 113 114
100 131 81 103 100 130 78 100 101
69 127 78 100 61 128 79 101 73
89 124 75 96 88 136 78 101 90
79 144 89 109 80 154 70 102 76
73 104 41 63 73 115 44 68 73
97 120 54 82 96 125 85 99 94
120 105 65 81 119 97 60 72 109
104 114 64 82 106 128 73 91 105
94 149 88 115 94 144 85 112 96
116 109 53 73 90 114 49 73 86
106 140 88 111 102 135 86 107 88
128 178 90 125 125 188 85 127 106
78 117 91 106 79 145 84 110 79
94 87 43 58 95 87 43 58 95
60 116 52 79 65 127 64 86 62
97 140 86 109 95 127 67 94 92
60 113 57 81 56 115 56 80 52
98 141 91 109 97 142 92 110 96
84 153 84 110 75 149 83 105 73
111 115 56 76 100 120 53 76 90
120 130 73 91 84 128 73 89 90
120 128 67 85 129 129 66 86 129
89 147 72 99 88 161 73 100 90
81 135 70 91 76 132 67 92 76
111 123 62 80 113 122 62 80 118
98 120 66 83 98 120 60 80 94
78 118 71 92 77 122 72 94 77
110 120 70 85 108 121 70 85 108
93 133 95 109 92 139 68 93 95
114 124 63 83 88 129 59 84 82
88 136 88 99 84 138 85 97 80
117 155 79 105 99 142 70 96 86
102 127 76 98 102 131 78 100 103
108 103 69 84 111 103 68 83 110
108 110 75 85 105 116 85 88 100
109 123 72 92 103 122 74 93 100
130 122 61 80 122 118 61 80 123
93 158 80 117 90 170 84 122 89
115 148 70 99 112 150 71 98 114
60 142 70 100 61 142 74 102 61
116 88 58 70 115 94 58 70 122
116 154 85 115 115 159 79 114 111
68 180 94 124 71 179 89 119 66
110 123 73 94 111 129 75 95 111
87 113 74 84 87 119 70 88 87
90 152 82 104 86 150 80 100 87
88 108 69 86 89 122 77 96 88
114 103 48 65 111 104 47 64 109
98 127 61 86 98 127 60 82 99
111 143 83 100 107 144 82 100 107
123 162 86 111 130 151 81 102 126
110 145 79 106 113 146 86 108 104
114 110 50 68 109 118 52 74 109
80 120 72 94 82 126 69 92 79
55 129 72 95 55 126 70 93 54
99 126 70 95 92 134 71 99 85
126 90 63 74 129 96 67 76 128
86 116 62 84 78 112 62 83 74
126 118 70 92 124 119 69 90 123
84 112 70 79 84 111 68 78 82
108 117 74 90 105 112 69 87 100
98 132 86 107 97 140 85 109 95
84 165 71 104 86 158 68 99 87
85 117 64 85 84 127 67 89 80
102 147 73 98 99 151 73 98 90
88 134 74 95 90 131 70 91 92
92 128 90 68 87 126 66 87 87
P4SBP P4DBP P4MBP P4HR P5SBP P5DBP P5MBP P5HR Fe-Ex
129 79 98 102 129 81 98 103 115
130 68 93 102 116 65 82 115 122
119 64 82 126 114 58 77 128 61
129 75 97 92 125 76 96 90 115
123 78 93 113 129 72 94 114 56
151 81 106 102 145 79 101 102 40
164 89 121 84 163 89 122 84 58
130 87 108 84 129 89 107 92 109
134 77 97 127 136 80 95 122 85
139 80 102 134 131 78 100 131 70
119 59 82 112 123 60 83 110 96
152 96 120 86 150 93 118 85 66
120 69 92 78 118 68 91 76 70
112 69 85 115 106 63 82 117 32
136 80 104 74 134 82 101 72 182
114 60 80 109 116 61 79 108 32
120 60 82 87 117 59 81 82 60
145 72 97 96 140 69 94 95 73
135 58 86 114 137 58 85 113 27
130 71 93 89 130 68 89 88 77
173 88 122 81 170 85 119 81 40
161 79 107 86 160 77 105 86 54
151 75 109 78 149 74 107 76 217
128 58 80 84 132 52 82 82 101
157 81 101 103 154 80 107 118 125
123 70 90 91 133 76 101 81 215
150 63 81 65 117 63 83 83 75
129 73 94 84 125 74 95 81 193
140 77 100 135 147 74 100 132 58
144 87 106 118 137 86 104 118 119
157 96 122 90 149 93 119 89 223
144 82 100 87 149 76 106 89 100
135 76 96 79 130 72 90 98 50
140 67 90 110 143 67 92 109 187
169 78 114 87 170 78 113 86 68
116 79 91 96 107 78 89 95 98
143 76 100 110 137 77 97 112 54
126 67 93 99 125 75 94 102 79
164 110 132 87 163 109 130 87 75
121 61 84 86 118 61 65 87 88
128 66 87 107 136 66 87 119 72
125 78 95 72 126 72 92 72 72
108 62 74 93 98 69 72 93 89
112 57 75 81 106 58 72 82 92
119 67 88 103 119 64 87 94 71
144 87 110 113 145 87 108 118 57
114 65 86 102 110 63 82 102 123
136 71 98 74 126 78 101 77 75
137 91 111 96 123 80 99 105 62
144 74 101 77 144 74 101 74 60
109 43 66 73 116 46 71 73 82
128 87 107 98 128 83 97 90 179
82 51 65 125 90 58 71 95 60
128 73 92 105 130 76 95 103 70
142 81 108 97 140 79 105 96 65
106 57 71 86 114 55 77 103 183
134 87 107 83 133 86 108 81 85
171 83 114 111 187 83 122 95 109
147 86 111 80 144 87 110 75 91
86 43 58 95 87 42 58 95 36
126 64 85 59 130 72 90 61 30
137 80 101 97 147 84 105 109 71
113 54 78 51 115 52 77 50 68
132 95 111 94 138 98 112 94 121
149 85 110 73 152 80 107 72 68
121 47 72 86 116 44 67 77 75
124 74 90 101 123 71 86 106 200
128 64 84 128 133 67 87 126 58
147 72 67 80 147 67 95 79 70
132 67 92 73 134 64 92 73 97
123 62 80 115 124 63 81 115 89
128 68 82 88 132 65 85 87 68
120 74 94 77 119 77 97 80 56
121 70 85 109 117 65 81 107 91
141 68 92 94 142 68 92 93 185
130 62 84 78 128 61 83 93 66
129 81 92 80 129 78 89 79 163
145 70 96 86 149 72 99 85 72
134 88 108 104 134 80 104 107 79
103 67 84 110 104 67 84 106 76
102 62 78 98 105 59 80 95 52
121 70 91 101 120 70 90 100 153
126 62 82 126 120 62 81 127 86
167 78 116 84 171 73 111 76 52
144 69 96 114 138 65 92 115 163
148 79 109 60 150 79 108 64 65
96 56 71 124 95 57 71 122 41
150 78 109 110 147 76 106 109 113
188 93 122 65 185 92 122 63 71
127 73 93 111 122 72 91 112 75
120 70 90 86 122 74 96 88 47
156 81 103 98 155 78 101 119 53
122 80 98 87 118 78 95 89 92
104 45 63 109 105 46 64 110 39
127 61 81 97 131 61 83 100 56
151 85 90 106 130 72 90 106 71
155 83 106 125 149 79 102 125 55
137 83 103 106 137 87 105 111 69
110 56 76 110 118 54 77 112 72
130 72 94 78 132 75 98 78 64
124 71 92 56 123 69 91 54 53
139 70 100 80 141 71 101 82 70
99 68 79 126 97 62 74 128 85
118 69 90 74 115 62 84 73 57
122 68 90 123 127 65 89 120 66
114 69 79 83 120 69 80 84 46
119 72 90 101 121 74 92 101 84
161 86 113 92 151 89 115 94 38
163 70 101 88 162 68 99 89 51
125 66 88 80 125 125 64 87 53
151 71 97 91 145 67 91 88 125
118 67 85 94 127 68 91 87 42
126 66 87 87 126 68 90 87 71
Fe-Rev Vec-Ex Vec-Rev Sd-Ex Iso-Ex Plasma1 plasma2 code
86 42 13 33 0.7 A
118 47 23 29 0 B
45 24 8 22 0.57 A
99 30 14 18 0 B
47 31 22 15 0 C
25 30 15 20 0.308 A
42 23 7 19 1.06 0.86 C
87 33 11 27 0 0 B
76 20 11 15 0.86 A
59 29 18 25 1.14 0.68 C
77 91 72 27 0.68 0.43 C
39 41 14 30 0 0 B
52 37 19 22 0 0 B
17 37 22 17 0.52 0.39 A
163 36 17 3 1.02 0.56 A
27 22 17 14 52 0.35 0.31 A
45 28 14 20 60 0 0 B
45 44 16 31 73 4.692 0.454 C
30 19 12 10 57 0 0 B
61 27 11 19 77 0.617 0.383 C
14 32 6 30 60 0.762 0.664 C
33 31 10 24 54 4.82 4.25 A
204 27 14 17 52 0.6 1.46 C
73 51 23 36 51 0 0 B
110 31 16 21 37 0 0 A
190 65 40 26 70 0.92 0.74 C
64 33 22 21 73 0.25 0.27 B
145 68 20 50 87 0.86 0.68 A
50 18 11 10 52 0.941 0.857 A
101 46 29 22 86 0.517 0.722 C
200 43 20 28 99 0.88 0.66 A
88 30 18 15 65 0.27 0.26 B
33 32 15 20 60 0.63 0.58 C
168 40 19 23 58 0 0 B
60 28 20 14 68 0.73 0.8 C
86 35 23 16 98 0.87 0.71 A
47 24 17 11 42 0 0 B
67 39 27 17 80 2.2 1.8 C
58 30 13 19 45 0.64 0.49 A
75 53 40 20 72 0 0 B
54 39 21 26 73 0 0 B
52 31 11 23 71 0.72 0.87 C
75 35 21 19 79 2.59 insufficient A
83 28 19 17 91 1.4 1.22 C
52 56 37 24 56 0 0 B
42 45 31 20 55 1 0.6 A
104 27 8 23 88 0 0 B
62 28 19 22 76 0.84 0.79 A
46 35 19 25 58 0 0 B
42 30 12 26 57 0.59 0.41 C
69 32 19 21 82 0.54 0.26 A
172 24 17 14 60 0 0 C
52 17 15 12 60 0 0 B
56 25 9 18 65 0 0 A
53 50 38 20 60 0.24 0.27 A
167 43 27 20 58 0.48 0.39 C
75 50 40 16 80 0 0 B
92 39 22 21 99 0.79 0.7 C
80 54 45 16 58 1.94 2.4 C
17 36 17 22 66 0 0 B
25 20 15 14 40 0.75 0.55 A
52 51 32 24 71 0 0 B
42 38 12 28 63 0.88 0.57 C
107 31 17 19 51 0 0 B
53 28 13 23 71 0.7 0.52 A
61 30 16 17 70 0.78 1.1 C
163 57 20 47 200 1.33 1 A
0.89 0.76 C
46 31 19 17 58 0 0 B
46 45 21 27 60 1.07 0.71 A
57 51 11 45 92 1.56 0.35 C
74 43 29 30 85 0 0 B
53 46 31 19 65 0.56 0.31 A
46 25 15 18 66 1.05 0.29 A
59 49 17 37 89 0 0 B
174 25 14 16 57 0.57 0.53 C
43 41 18 27 72 0.88 0.61 C
149 31 17 20 52 0 0 B
66 37 31 14 63 0.704 1.23 C
67 29 17 16 79 0 0 A
59 27 10 21 77 0 0 B
43 24 15 15 47 0.48 0.47 A
126 33 31 23 103 0 0 B
73 35 20 19 85 0.8 0.82 C
30 37 15 29 72 0.64 0.44 C
154 52 41 18 68 0 0 B
56 30 21 17 60 0.85 0.66 A
29 21 9 19 41 0 0 B
89 33 9 27 83 0.66 0 C
59 21 9 15 76 0.67 0.57 A
66 45 36 15 45 0 0 A
36 22 11 13 47 0.33 0.59 C
41 23 11 17 53 1.209 1.043 A
80 27 15 17 92 0 0 B
32 24 17 10 49 0.76 0.75 A
41 31 16 18 56 0 0 B
46 38 13 28 70 0.47 0.34 A
48 19 12 13 59 0 0 C
56 24 11 15 69 0.73 0.56 C
55 30 13 20 72 0 0 B
48 56 40 28 64 0 0 B
49 23 19 10 53 1.16 1.1 A
51 40 21 23 60 1.06 0.76 A
55 42 22 21 80 0.38 1.1 C
38 31 12 26 55 0.77 0.38 C
49 26 9 21 60 0.13 0.14 B
44 37 35 7 61 interferenc 2.74 C
79 19 14 11 84 0.82 1.39 C
22 30 14 22 62 0 0 B
43 20 12 9 51 0.67 0.59 A
30 36 13 26 53 0.57 0.45 A
106 34 15 25 60 0.86 0.63 C
28 32 18 19 62 2.13 0.28 B
61 17 7 14 68 0 0 B
